<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Catal.</journal-id>
<journal-title>Frontiers in Catalysis</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Catal.</abbrev-journal-title>
<issn pub-type="epub">2673-7841</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">887458</article-id>
<article-id pub-id-type="doi">10.3389/fctls.2022.887458</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Catalysis</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Hydrophobic Outer Membrane Pores Boost Testosterone Hydroxylation by Cytochrome P450 BM3 Containing Cells</article-title>
<alt-title alt-title-type="left-running-head">Bertelmann et al.</alt-title>
<alt-title alt-title-type="right-running-head">Hydrophobic Pores Boost Testosterone Hydroxylation</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bertelmann</surname>
<given-names>Carolin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1690694/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mock</surname>
<given-names>Magdalena</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koch</surname>
<given-names>Rainhard</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schmid</surname>
<given-names>Andreas</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>B&#xfc;hler</surname>
<given-names>Bruno</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/255175/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Solar Materials, Helmholtz Centre for Environmental Research GmbH &#x2013; UFZ</institution>, <addr-line>Leipzig</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Engineering and Technology</institution>, <institution>Bayer AG</institution>, <addr-line>Leverkusen</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/243168/overview">Dirk Tischler</ext-link>, Ruhr University Bochum, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/935404/oerview">Aitao Li</ext-link>, Hubei University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/445534/overview">Florian Rudroff</ext-link>, Vienna University of Technology, Austria</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Bruno B&#xfc;hler, <email>bruno.buehler@ufz.de</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Biocatalysis, a section of the journal Frontiers in Catalysis</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>2</volume>
<elocation-id>887458</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Bertelmann, Mock, Koch, Schmid and B&#xfc;hler.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Bertelmann, Mock, Koch, Schmid and B&#xfc;hler</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The implementation of biocatalytic steroid hydroxylation processes at an industrial scale still suffers from low conversion rates. In this study, we selected variants of the self-sufficient cytochrome P450 monooxygenase BM3 from <italic>Bacillus megaterium</italic> (BM3) for the hydroxylation of testosterone either at the 2&#x3b2;- or 15&#x3b2;-position. Recombinant <italic>Escherichia coli</italic> cells were used as biocatalysts to provide a protective environment for recombinant enzymes and to ensure continuous cofactor recycling <italic>via</italic> glucose catabolism. However, only low initial whole-cell testosterone conversion rates were observed for resting cells. Results obtained with different biocatalyst formats (permeabilized cells, cell-free extracts, whole cells) indicated a limitation in substrate uptake, most likely due to the hydrophilic character of the outer membrane of <italic>E. coli</italic>. Thus, we co-expressed nine genes encoding hydrophobic outer membrane proteins potentially facilitating steroid uptake. Indeed, the application of four candidates led to increased initial testosterone hydroxylation rates. Respective whole-cell biocatalysts even exceeded activities obtained with permeabilized cells or cell-free extracts. The highest activity of 34&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> was obtained for a strain containing the hydrophobic outer membrane protein AlkL from <italic>Pseudomonas putida</italic> GPo1 and the BM3 variant KSA14m. Overall, we show that the straightforward application of hydrophobic outer membrane pores can boost whole-cell steroid conversion rates and thus be game-changing with regard to industrial steroid production efficiency.</p>
</abstract>
<kwd-group>
<kwd>whole-cell biocatalysis</kwd>
<kwd>steroid hydroxylation</kwd>
<kwd>substrate uptake</kwd>
<kwd>cytochrome P450 monooxygenase</kwd>
<kwd>hydrophobic membrane pores</kwd>
<kwd>AlkL</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Steroid-based drugs account for one of the largest and still expanding sectors in the pharmaceutical industry (<xref ref-type="bibr" rid="B74">Tong and Dong, 2009</xref>). Their broad spectrum of pharmaceutical activities is reflected in the prominent role they play, e.g., in contraceptives, anti-inflammatory agents, or cancer treatments (<xref ref-type="bibr" rid="B11">Bureik and Bernhardt, 2007</xref>; <xref ref-type="bibr" rid="B16">Donova and Egorova, 2012</xref>; <xref ref-type="bibr" rid="B17">Donova, 2017</xref>). Hydroxylated steroid derivatives frequently show higher biological activities than their more hydrophobic non-hydroxylated analogs, rendering steroid hydroxylations particularly relevant (<xref ref-type="bibr" rid="B16">Donova and Egorova, 2012</xref>). As number and position of hydroxyl groups are decisive for the biological activity of steroids, highly selective hydroxylation is crucial (<xref ref-type="bibr" rid="B11">Bureik and Bernhardt, 2007</xref>; <xref ref-type="bibr" rid="B16">Donova and Egorova, 2012</xref>). Desired reactions often are not accessible by chemical means, making biocatalysis a promising highly selective and often eco-efficient alternative for steroid functionalization (<xref ref-type="bibr" rid="B11">Bureik and Bernhardt, 2007</xref>; <xref ref-type="bibr" rid="B32">Julsing et al., 2008</xref>; <xref ref-type="bibr" rid="B17">Donova, 2017</xref>).</p>
<p>Several microorganisms show native steroid-modifying activities and are regularly applied at industrial scale. However, respective processes typically suffer from low productivities, defined as amount of product produced per time and volume, and undesired side-reactions (<xref ref-type="bibr" rid="B11">Bureik and Bernhardt, 2007</xref>; <xref ref-type="bibr" rid="B21">Fern&#xe1;ndez-Cabez&#xf3;n et al., 2018</xref>). Thus, enzyme discovery as well as enzyme and strain engineering have been of immense interest in recent decades (<xref ref-type="bibr" rid="B17">Donova, 2017</xref>; <xref ref-type="bibr" rid="B21">Fern&#xe1;ndez-Cabez&#xf3;n et al., 2018</xref>), giving rise to a huge variety of steroid hydroxylating cytochrome P450 monooxygenases (CYP450s) covering virtually all possible specificities (<xref ref-type="bibr" rid="B3">Bernhardt, 2006</xref>; <xref ref-type="bibr" rid="B11">Bureik and Bernhardt, 2007</xref>; <xref ref-type="bibr" rid="B17">Donova, 2017</xref>; <xref ref-type="bibr" rid="B73">Szaleniec et al., 2018</xref>).</p>
<p>Employing CYP450s of mammalian origin appears attractive due to their natural role in steroid synthesis and conversion (<xref ref-type="bibr" rid="B16">Donova and Egorova, 2012</xref>; <xref ref-type="bibr" rid="B17">Donova, 2017</xref>). However, they often suffer from low enzyme activities severely hampering application (<xref ref-type="bibr" rid="B3">Bernhardt, 2006</xref>; <xref ref-type="bibr" rid="B76">Urlacher and Schmid, 2006</xref>; <xref ref-type="bibr" rid="B32">Julsing et al., 2008</xref>). Bacterial CYP450s typically provide higher activities and high levels of soluble expression in recombinant microorganisms. The vast majority of CYP450s features separate components involved in the shuttling of electrons from NAD(P)H to the monooxygenase subunit (<xref ref-type="bibr" rid="B3">Bernhardt, 2006</xref>). Subunits need to be expressed in a stable and active form and in the optimal ratio (<xref ref-type="bibr" rid="B50">Murdock et al., 1993</xref>; <xref ref-type="bibr" rid="B71">Staijen et al., 2000</xref>) which is likely to confine the biotransformation efficiency (<xref ref-type="bibr" rid="B18">Duetz et al., 2001</xref>). Biocatalyst efficiency, namely the enzyme turnover rate <italic>k</italic>
<sub>
<italic>cat</italic>
</sub> (s<sup>&#x2212;1</sup>), may therefore benefit from a fusion of subunits as it is the case for native CYP450 BM3 (BM3, in CYP450 nomenclature: CYP102A1) from <italic>Bacillus megaterium</italic> ATC14581 featuring the highest known CYP450 activity (<xref ref-type="bibr" rid="B51">Narhi and Fulco, 1986</xref>, <xref ref-type="bibr" rid="B52">1987</xref>; <xref ref-type="bibr" rid="B54">Noble et al., 1999</xref>). For this fatty acid monooxygenase, which does not accept steroids as substrates (<xref ref-type="bibr" rid="B83">van Vugt-Lussenburg et al., 2006</xref>), Kille <italic>et al.</italic> developed a set of variants with promising activities as well as regio- and diastereoselectivities for testosterone hydroxylation (<xref ref-type="bibr" rid="B38">Kille et al., 2011</xref>), constituting an interesting foundation for efficient steroid hydroxylation.</p>
<p>CYP450s are cofactor-dependent and instable in isolated form and thus are preferably applied in metabolically active cells (<xref ref-type="bibr" rid="B18">Duetz et al., 2001</xref>; <xref ref-type="bibr" rid="B68">Schrewe et al., 2013</xref>), with self- and enzyme regeneration and reactive oxygen species (ROS) degradation as important stabilizing factors (<xref ref-type="bibr" rid="B87">Woodley, 2006</xref>). However, microbial cell envelopes typically feature a hydrophilic outer face, established by a lipopolysaccharide layer and the hydrophilic nature of outer membrane porins, e.g., in Gram-negatives (<xref ref-type="bibr" rid="B42">Leive, 1974</xref>; <xref ref-type="bibr" rid="B53">Nikaido, 2003</xref>; <xref ref-type="bibr" rid="B14">Chen, 2007</xref>; <xref ref-type="bibr" rid="B68">Schrewe et al., 2013</xref>). This restrains the uptake of hydrophobic substrates (<xref ref-type="bibr" rid="B13">Carter et al., 2003</xref>; <xref ref-type="bibr" rid="B67">Schrewe et al., 2011</xref>; <xref ref-type="bibr" rid="B24">Grant et al., 2014</xref>), including steroids (<xref ref-type="bibr" rid="B88">Zehentgruber et al., 2010a</xref>; <xref ref-type="bibr" rid="B89">Zehentgruber et al., 2010b</xref>; <xref ref-type="bibr" rid="B59">Putkaradze et al., 2019</xref>). The heterologous co-expression of genes encoding hydrophobic outer membrane pores can facilitate hydrophobic substrate uptake into metabolically active cells, as it has been shown for the bioconversion of alkanes (<xref ref-type="bibr" rid="B33">Julsing et al., 2012</xref>; <xref ref-type="bibr" rid="B24">Grant et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Call et al., 2016</xref>; <xref ref-type="bibr" rid="B30">Hsieh et al., 2018</xref>), long-chain fatty acids (<xref ref-type="bibr" rid="B66">Schneider et al., 1998</xref>; <xref ref-type="bibr" rid="B31">Jeon et al., 2018</xref>), fatty acid methyl esters (<xref ref-type="bibr" rid="B33">Julsing et al., 2012</xref>; <xref ref-type="bibr" rid="B41">Ladkau et al., 2016</xref>; <xref ref-type="bibr" rid="B82">van Nuland et al., 2016</xref>), terpenes (<xref ref-type="bibr" rid="B15">Cornelissen et al., 2013</xref>; <xref ref-type="bibr" rid="B60">Ruff et al., 2016</xref>), and aromatics (<xref ref-type="bibr" rid="B60">Ruff et al., 2016</xref>).</p>
<p>In this study, we evaluate the steroid hydroxylation performance of highly active BM3 variants in living <italic>Escherichia coli</italic> cells and follow up the hypotheses that the outer membrane of Gram-negative bacteria forms an effective barrier for steroids and that this barrier can be relieved by introducing hydrophobic pores. Thereby, 2&#x3b2;- or 15&#x3b2;-hydroxylations of testosterone served as model reactions and the performance of permeabilized and intact cells was compared (<xref ref-type="fig" rid="F1">Figure 1</xref>). Further, different outer membrane proteins were evaluated for their potential to improve specific steroid hydroxylation activities of living cells (<xref ref-type="sec" rid="s10">Supplementary Table S1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Biocatalyst formats for the hydroxylation of testosterone (T) to 2&#x3b2;- and 15&#x3b2;-hydroxytestosterone (2/15&#x3b2;-OH-T) using self-sufficient CYP450 BM3 variants (BM3). <bold>(A)</bold> Permeabilized cells supplied with glucose and glucose dehydrogenase (GDH) for NADPH regeneration. Efficient steroid diffusion into cells can be assumed. <bold>(B)</bold> Intact living cells recycling NADPH <italic>via</italic> active glucose catabolism. They are hypothesized to require hydrophobic outer membrane proteins (OMP) for efficient steroid uptake and secretion.</p>
</caption>
<graphic xlink:href="fctls-02-887458-g001.tif"/>
</fig>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Gene Synthesis, Oligonucleotides, and Chemicals</title>
<p>Custom synthesized genes and oligonucleotides were purchased from Eurofins (Ebersberg, Germany). 2&#x3b2;- and 15&#x3b2;-hydroxytestosterone were purchased from Steraloids Inc. (Newport, RI, United States). All other chemicals were obtained from AppliChem (Darmstadt, Germany), Carl Roth (Karlsruhe, Germany), Chemsolute (Renningen, Germany), or Sigma-Aldrich (Steinheim, Germany) in the highest purity available.</p>
</sec>
<sec id="s2-2">
<title>Generation of Recombinant Bacterial Strains</title>
<p>Enzymes (Phusion High-Fidelity Polymerase, restriction enzymes, T5 exonuclease, Taq DNA ligase), dNTPS, and the corresponding buffers were purchased from Thermo Scientific Molecular Biology (St. Leon-Rot, Germany) or New England Biolabs (Frankfurt/Main, Germany). Plasmid isolation and purification of DNA from agarose gels was performed according to the manufacturer&#x2019;s instructions of the respective kits from Macherey-Nagel (D&#xfc;ren, Germany). Electro-competent <italic>E. coli</italic> cells were prepared according to standard procedures (<xref ref-type="bibr" rid="B61">Sambrook and Russell, 2001</xref>) and transformed <italic>via</italic> electroporation (2500&#xa0;V, Eppendorf Eporator<sup>&#xae;</sup>, Hamburg, Germany).</p>
<p>Microbial strains and plasmids used in this work are listed in <xref ref-type="sec" rid="s10">Supplementary Table S2</xref>. <italic>E. coli</italic> DH5&#x3b1; was used for cloning purposes, whereas <italic>E. coli</italic> BL21-Gold(DE3) was used for expression and biotransformation studies. The plasmids pETM11_KSA1, pETM11_KSA2, pETM11_KSA3, and pETM11_KSA14 were constructed according to the publication of <xref ref-type="bibr" rid="B38">Kille et al. (2011)</xref>. Plasmids harboring genes encoding the respective outer membrane proteins were constructed as shown in <xref ref-type="sec" rid="s10">Supplementary Table S3</xref>. The respective genes were either ordered as gene synthesis constructs or obtained from genomic DNA. Successful cloning was confirmed by sequencing (Genewiz Germany GmbH, Leipzig, Germany).</p>
</sec>
<sec id="s2-3">
<title>Cultivation of <italic>E. coli</italic> Strains</title>
<p>For bacterial growth and heterologous protein synthesis, cells were grown in lysogeny broth (LB) medium (<xref ref-type="bibr" rid="B61">Sambrook and Russell, 2001</xref>), modified terrific broth (TB) (<xref ref-type="bibr" rid="B38">Kille et al., 2011</xref>), or M9 medium (<xref ref-type="bibr" rid="B61">Sambrook and Russell, 2001</xref>) supplemented with 0.1% (v/v) US&#x2a; trace element solution (<xref ref-type="bibr" rid="B57">Panke et al., 1999</xref>), 2&#xa0;mM MgSO<sub>4</sub>, and 0.5% (w/v) <sc>d</sc>-glucose as sole carbon and energy source. Cultivations were conducted in a Multitron shaker (Infors, Bottmingen, Switzerland).</p>
<p>Microorganisms from a frozen glycerol stock were cultivated in LB medium (supplemented with 50&#xa0;&#x3bc;g mL<sup>&#x2212;1</sup> kanamycin for plasmid-containing cells) at 37&#xb0;C and 200&#xa0;rpm for 6&#x2013;8&#xa0;h. From the LB culture, 10&#xa0;mL of either M9 or TB medium were inoculated and incubated at 30&#xb0;C for 14&#x2013;16&#xa0;h. These precultures were used to inoculate the same media to an optical density of 0.2 at 450&#xa0;nm (OD<sub>450</sub>). Heterologous gene expression was induced in the early exponential phase (OD<sub>450</sub> &#x223c;0.6) by addition of 0.1&#xa0;mM isopropyl <italic>&#x3b2;</italic>-<sc>d</sc>-1-thiogalactopyranoside (IPTG). In case of cultivation in M9 medium, 0.5&#xa0;mM of the heme precursor 5-aminolevulinic acid was simultaneously added for enhanced heme synthesis. Cells were harvested 5&#xa0;h after induction by centrifugation (5,000&#xa0;g, 5&#xa0;min, 4&#xb0;C) for the preparation of permeabilized cells, resting cells, or cell-free extracts. For the isolation of total membrane fractions, cell pellets were stored at &#x2212;20&#xb0;C until further processing.</p>
</sec>
<sec id="s2-4">
<title>Biotransformation With Permeabilized Cells</title>
<p>Specific activities of permeabilized cells were determined according to a modified version of the protocol described by <xref ref-type="bibr" rid="B38">Kille et al. (2011)</xref>. Cells were harvested from TB cultures 5&#xa0;h after induction, washed once with P450 washing buffer (100&#xa0;mM potassium phosphate, pH 7.4, 5% (v/v) glycerol), and resuspended to a cell concentration of 1&#xa0;g<sub>CDW</sub> L<sup>&#x2212;1</sup> in P450 reaction buffer (100&#xa0;mM potassium phosphate, pH 7.4, 5% (v/v) glycerol, 5% (w/v) glucose, 5&#xa0;mM EDTA, 0.25&#xa0;mM NADP<sup>&#x2b;</sup>, 1&#xa0;U mL<sup>&#x2212;1</sup> glucose dehydrogenase). The cell suspension was immediately frozen in liquid nitrogen and then thawed at room temperature. One mL of sample was transferred to screw-capped glass tubes (12&#xa0;mL) and equilibrated in a water bath at 30&#xb0;C and 250&#xa0;rpm for 15&#xa0;min. The biotransformation was then started by adding 10&#xa0;&#xb5;L of a 100&#xa0;mM testosterone stock solution in DMSO, resulting in final concentrations of 1&#xa0;mM testosterone and 1% (v/v) DMSO. Reactions were terminated after a specific incubation time (given in figures and corresponding descriptions) by adding 12.5&#xa0;&#xb5;L HCl (1&#xa0;M) per 100&#xa0;&#xb5;L resting cell suspension. Acetonitrile was added to the samples (50% v/v) to dissolve precipitated steroids, followed by mixing (2000&#xa0;rpm, 5&#xa0;min, 4&#xb0;C) and centrifugation (17,000&#xa0;g, 5&#xa0;min, 4&#xb0;C) for biomass removal. The resulting supernatant was stored at &#x2212;20&#xb0;C until further analysis. Specific activities are given in U g<sub>CDW</sub>
<sup>&#x2212;1</sup>, with 1&#xa0;U defined as the activity forming 1&#xa0;&#xb5;mol of product per min, and were retrieved via quantification of accumulated product divided by the biomass applied.</p>
</sec>
<sec id="s2-5">
<title>
<italic>In Vivo</italic> Biotransformation With Resting Cells</title>
<p>Fresh cells harvested 5&#xa0;h after induction from an exponentially growing M9 culture were washed once and resuspended to a cell concentration of 1&#xa0;g<sub>CDW</sub> L<sup>&#x2212;1</sup> in 100&#xa0;mM potassium phosphate buffer (pH 7.4) supplemented with 1% (w/v) glucose as the source for energy and reduction equivalents. One mL of resting cell suspension was filled into screw-capped glass tubes (12&#xa0;mL) and equilibrated at 30&#xb0;C and 250&#xa0;rpm for 15&#xa0;min. Reaction start and termination as well as sampling were performed as described above for biotransformations with permeabilized cells.</p>
</sec>
<sec id="s2-6">
<title>
<italic>In Vitro</italic> Biotransformation With Cell-Free Extracts</title>
<p>Cells were harvested from induced exponentially growing M9 cultures, and cell pellets were resuspended in 100&#xa0;mM potassium phosphate buffer (pH 7.4) to a concentration of 3&#xa0;g<sub>CDW</sub> L<sup>&#x2212;1</sup>. Subsequently, cells were disrupted by three passages through a French Press (6.9&#xa0;MPa, Glenn Mills Inc., Clifton, NJ, United States). Cell debris was removed by centrifugation at 12,000&#xa0;g for 15&#xa0;min at 4&#xb0;C. One mL of supernatant was transferred to screw-capped glass tubes (12&#xa0;mL), equilibrated at 30&#xb0;C and 250&#xa0;rpm for 15 min, and supplied with 10&#xa0;&#xb5;L of a 50&#xa0;mM NADPH stock solution in the same buffer. The reaction was started by adding 10&#xa0;&#xb5;L of a 100&#xa0;mM testosterone stock solution in DMSO, resulting in final concentrations of 0.5&#xa0;mM NADPH, 1&#xa0;mM testosterone, and 1% (v/v) DMSO. Reactions were terminated and samples were treated as described above.</p>
</sec>
<sec id="s2-7">
<title>Isolation of Total Membrane Fractions</title>
<p>Cell pellets were thawed in ice, resuspended in a 100&#xa0;mM potassium phosphate buffer (pH 7.4) to a concentration of 3&#x2013;5&#xa0;g<sub>CDW</sub> L<sup>&#x2212;1</sup>, and disrupted by two passages through a French Press (6.9 MPa, Glenn Mills Inc.). The resulting crude cell extract was centrifuged at 12,000&#xa0;g for 15&#xa0;min at 4&#xb0;C followed by centrifugation of the supernatant at 200,000&#xa0;g and 4&#xb0;C for 2&#xa0;h. The resulting pellet was resuspended in the same buffer and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE, see below).</p>
</sec>
<sec id="s2-8">
<title>Analytical Methods</title>
<p>Biomass concentrations were determined photometrically as the optical density at a wavelength of 450&#xa0;nm (Libra S11, Biochrom Ltd., Cambridge, United Kingdom) with one OD<sub>450</sub> unit corresponding to 0.166&#xa0;g<sub>CDW</sub> L<sup>&#x2212;1</sup> (<xref ref-type="bibr" rid="B92">Blank et al., 2008</xref>).</p>
<p>Protein concentrations were analyzed <italic>via</italic> Bradford Dye Reagent (Alfa Aesar, Kandel, Germany) according to the manufacturer&#x2019;s instructions using bovine serum albumin as protein standard. Monitoring of protein synthesis was performed by harvesting 80&#xa0;&#xb5;g of cell dry weight (CDW) from cultures followed by SDS-PAGE according to <xref ref-type="bibr" rid="B93">Laemmli (1970)</xref>. Proteins extracted from 15 &#xb5;g<sub>CDW</sub> were loaded per lane and stained with Coomassie Brilliant Blue R-250. For cell-free extract and membrane fraction analysis, 7.5&#xa0;&#xb5;g of total protein were loaded per lane. PageRuler&#x2122; Prestained Protein Ladder (Thermo Fisher Scientific, Waltham, MA, United States) was used as reference.</p>
<p>Steroid concentrations were determined by HPLC using a Dionex Ultimate 3,000 system (Thermo Fisher Scientific) equipped with an Accucore C18 column (150 &#xd7; 3&#xa0;mm, 2.6&#xa0;&#xb5;m particle size, Thermo Fisher Scientific). An eluent consisting of 40% acetonitrile in ultrapure water was used at a flow rate of 0.6&#xa0;mL min<sup>&#x2212;1</sup>. The column oven temperature was set to 40&#xb0;C and a sample volume of 5&#xa0;&#xb5;L was injected. Steroids were detected at 245&#xa0;nm using an UV detector and quantified based on calibration curves.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Testosterone Hydroxylation by <italic>E. coli</italic> BL21-Gold(DE3) Harboring Engineered BM3 Variants</title>
<p>In a previous study, Kille <italic>et al.</italic> developed a library of engineered BM3 variants capable of regio- and stereoselective hydroxylation of testosterone either at the 2&#x3b2;- or the 15&#x3b2;-position (<xref ref-type="bibr" rid="B38">Kille et al., 2011</xref>). Genes encoding the respective BM3 variants were heterologously expressed in <italic>E. coli</italic> BL21-Gold(DE3) <italic>via</italic> the <italic>lac</italic>-based T7 expression system. Promising variants showed good conversions and regioselectivities, from which volumetric activities of up to 0.58 U L<sup>&#x2212;1</sup> can be estimated (<xref ref-type="sec" rid="s10">Supplementary Table S4</xref>). An important remark is that cell preparation included the addition of EDTA and a freeze-thawing step which is prone to involve cell membrane permeabilization (<xref ref-type="bibr" rid="B20">Felix, 1982</xref>; <xref ref-type="bibr" rid="B14">Chen, 2007</xref>). Thus, cells presumably were incapable of intracellular cofactor regeneration (<xref ref-type="bibr" rid="B32">Julsing et al., 2008</xref>; <xref ref-type="bibr" rid="B33">Julsing et al., 2012</xref>; <xref ref-type="bibr" rid="B68">Schrewe et al., 2013</xref>), which is corroborated by the use of an extracellular cofactor regeneration system (<xref ref-type="bibr" rid="B38">Kille et al., 2011</xref>). The study presents long-term data (24&#xa0;h of biotransformation). In order to assess biocatalyst efficiency in detail, we set out to determine initial and specific catalytic rates for permeabilized as well as living cells equipped with the promising BM3 variants KSA1, KSA2, KSA3, or KSA14.</p>
<p>Constructed strains were based on pETM11 and <italic>E. coli</italic> BL21-Gold(DE3) according to <xref ref-type="bibr" rid="B38">Kille et al. (2011)</xref> (<xref ref-type="sec" rid="s10">Supplementary Table S2</xref>, <xref ref-type="sec" rid="s10">Supplementary Figure S1A</xref>). For cell cultivation and heterologous protein synthesis in TB medium, the protocol for microplate cultivation (<xref ref-type="bibr" rid="B38">Kille et al., 2011</xref>) was adapted to shake flask scale. As expected, permeabilized cells containing KSA1, KSA2, and KSA3 primarily produced 2&#x3b2;-hydroxytestosterone, whereas 15&#x3b2;-hydroxytestosterone was detected as main product of KSA14 (<xref ref-type="sec" rid="s10">Supplementary Table S5</xref>). Volumetric activities for 24&#xa0;h of biotransformation were in a similar range as previously reported (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>). Initial activities within the first 10&#xa0;min were found to exceed long-term activities by factors of 7.8&#x2013;19.8, indicating that testosterone hydroxylation rates do not remain constant in the experimental setup chosen. Interestingly, one particular KSA14 clone exhibited a 2-fold higher initial activity and similar 15&#x3b2;-regioselectivity (<xref ref-type="sec" rid="s10">Supplementary Table S5</xref>). Sequencing of the plasmid from this clone revealed four additional nucleotide exchanges compared to the original <italic>ksa14</italic> gene, leading to two missense mutations (K224E, V314I) and two silent mutations (L78L, L871L). Both amino acid exchanges are located in the BM3 monooxygenase subunit and thus are likely to affect the catalytic properties of the enzyme. For example, K224 forms salt bridges with the residues involved in the opening and closing of the substrate channel (<xref ref-type="bibr" rid="B86">Whitehouse et al., 2012</xref>). This variant is hereafter designated as KSA14m.</p>
<p>Compared to the wildtype strain (specific growth rate &#xb5; &#x3d; 0.85 &#xb1; 0.04&#xa0;h<sup>&#x2212;1</sup> at 30&#xb0;C in TB medium), the recombinant strains after induction showed a shorter phase of exponential growth, followed by a growth rate reduction which may be due to a metabolic burden of BM3 expression (<xref ref-type="fig" rid="F2">Figure 2A</xref>). However, growth of the empty vector control was even slower than that of BM3-containing strains and involved the synthesis of two unexpected 32 and 38&#xa0;kDa proteins (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Analysis of open reading frames on the empty vector revealed that the so-called max dimerization protein 1 (NCBI accession number NP_002348) may be synthesized. However, its molecular weight is estimated to be only 25&#xa0;kDa, which does not fit to the observed protein weights.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Performance of <italic>E. coli</italic> BL21-Gold(DE3) strains carrying pETM11 with genes encoding the respective BM3 variants compared to the wildtype (WT) and an empty vector control (EV) strain during and after cultivation in TB medium. <bold>(A)</bold> Bacterial growth in TB medium upon induction with 0.1&#xa0;mM IPTG. <bold>(B)</bold> SDS-PAGE analysis of the different strains 5&#xa0;h after induction, with the band at 119&#xa0;kDa representing the respective BM3 variant (black arrow). For the empty vector strain, two unidentified proteins (32 and 38&#xa0;kDa, grey arrows) were observed. <bold>(C)</bold> Initial (10&#xa0;min) testosterone hydroxylation activities of permeabilized and resting cells. Activity assays were conducted as described in the Materials and Methods section. <bold>(D)</bold> Conversion of testosterone (based on product formation) by the different cell formats 1 and 24&#xa0;h after substrate addition. The bars represent average values and standard deviations of two biological replicates (n.d., no product formation detected).</p>
</caption>
<graphic xlink:href="fctls-02-887458-g002.tif"/>
</fig>
<p>The high expression levels of the respective BM3 variants (<xref ref-type="fig" rid="F2">Figure 2B</xref>) enabled initial specific activities ranging from 1.25 &#xb1; 0.47 to 10.93 &#xb1; 1.00&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> for permeabilized cells of the different strains (<xref ref-type="fig" rid="F2">Figure 2C</xref>), whereas KSA14m hydroxylated testosterone at a significantly higher rate of 22.73 &#xb1; 1.02&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup>. To investigate if intact cells enable similar specific testosterone hydroxylation activities as permeabilized cells, non-growing living (i.e., resting) cells were prepared after cultivation and heterologous gene expression in TB medium and employed in activity assays. Direct comparison revealed 4.2 to 10.7-fold lower initial activities in the range of 0.26 &#xb1; 0.01 to 1.02 &#xb1; 0.06&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> for KSA1, KSA2, KSA3, and KSA14 (<xref ref-type="fig" rid="F2">Figure 2C</xref>). KSA14m containing cells again showed the highest testosterone hydroxylation rate (8.94 &#xb1; 0.49 U&#xa0;g<sub>CDW</sub>
<sup>&#x2212;1</sup>, 2.5-fold lower than in permeabilized cell format). Regioselectivity was not or only slightly reduced compared to permeabilized cells (<xref ref-type="sec" rid="s10">Supplementary Table S5</xref>). Furthermore, permeabilized cells generally demonstrated higher conversions than resting cells 1&#xa0;hour after substrate addition (<xref ref-type="fig" rid="F2">Figure 2D</xref>). This however changed during the following 23&#xa0;h, after which resting cells of some strains showed higher conversions than permeabilized cells. It has to be mentioned that solubility limits of testosterone and the 15&#x3b2;-hydroxylated product in the aqueous assay setup (RCA buffer supplemented with glucose and 1% (v/v) DMSO) amounted to 66 and 565&#xa0;&#x3bc;M, respectively. Depicted conversions after 1 and 24&#xa0;h of biotransformation were calculated based on product formation and need to be interpreted carefully when exceeding the aqueous solubility limit (conversions &#x3e;56%).</p>
</sec>
<sec id="s3-2">
<title>Heterologous BM3 Synthesis in Defined Media</title>
<p>High CYP450 levels led to noticeably impaired growth of the recombinant bacterial strains in TB medium, pointing to metabolic burden effects. High oxygenase levels have been reported to affect host cell physiology (<xref ref-type="bibr" rid="B78">van Beilen et al., 2003</xref>; <xref ref-type="bibr" rid="B10">B&#xfc;hler et al., 2008</xref>) and thus do not necessarily lead to higher whole-cell activities (<xref ref-type="bibr" rid="B62">Sch&#xe4;fer et al., 2020</xref>). In contrast to complex media like TB, defined media usually lead to slower bacterial growth and lower metabolic activity, including heterologous gene expression and protein synthesis, but are more feasible for process scale up. We thus also tested M9 medium for cultivation.</p>
<p>In contrast to modified TB medium, all recombinant strains showed exponential growth in M9 medium, which was not impaired compared to the wildtype, also not upon induction (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Even though BM3 levels after 5&#xa0;h of induction were lower in M9 medium compared to TB medium (<xref ref-type="fig" rid="F3">Figure 3B</xref>), resting cells showed similar initial specific activities, ranging from 0.26 &#xb1; 0.01&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> to 1.06 &#xb1; 0.02&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup>. The KSA14m strain again displayed a noticeably higher activity of 9.75 &#xb1; 1.60&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Interestingly, regioselectivity was slightly lower (<xref ref-type="sec" rid="s10">Supplementary Table S5</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Performance of <italic>E. coli</italic> BL21-Gold(DE3) strains carrying pETM11 with genes encoding the respective BM3 variants compared to the wildtype and an empty vector control strain during and after cultivation in M9 minimal medium supplemented with 0.5% (w/v) glucose. <bold>(A)</bold> Bacterial growth in M9 medium upon induction with 0.1&#xa0;mM IPTG and addition of 0.5&#xa0;mM 5-aminolevulinic acid. <bold>(B)</bold> SDS-PAGE analysis of the different strains 5&#xa0;h after induction, with the band at 119&#xa0;kDa representing the respective BM3 variant (black arrow). For the empty vector strain, two unidentified proteins (32 and 38&#xa0;kDa, grey arrows) were observed. <bold>(C)</bold> Initial (10&#xa0;min) and long-term (24&#xa0;h) testosterone hydroxylation activities of resting cells. <bold>(D)</bold> Activities of the KSA14m strain in different biocatalyst formats are compared. Activity assays were performed as described in the Materials and Methods section. The bars represent average values and standard deviations of two biological replicates (n.d., no product formation detected).</p>
</caption>
<graphic xlink:href="fctls-02-887458-g003.tif"/>
</fig>
<p>In summary, the choice of cultivation medium did not affect the activity of intact cells. However, selection of a suitable biocatalyst format proved to be pivotal for higher specific testosterone hydroxylation rates. The resting-cell format appears less suitable for BM3-catalyzed testosterone hydroxylation than the permeabilized-cell format, suffering from impaired substrate uptake. It however is clearly superior regarding cofactor regeneration and biocatalyst stability, making cell engineering for improved substrate uptake a strategy of choice.</p>
</sec>
<sec id="s3-3">
<title>Testosterone Hydroxylation by KSA14m in Cell-Free Extracts Versus Whole Cells</title>
<p>As the strain containing KSA14m displayed the highest specific testosterone hydroxylation activity, it was used to investigate the possible substrate uptake limitation. Cells cultivated in M9 medium were either used for the preparation of intact resting cells or disrupted to generate cell-free extracts, for which steroid hydroxylation is not subject to mass transfer limitation over cellular membranes. A specific activity of 34.8 &#xb1; 1.5&#xa0;U per g of total protein was obtained with cell-free extracts, which, assuming that standard <italic>E. coli</italic> cells consist of 55% total protein (<xref ref-type="bibr" rid="B64">Schmidt et al., 2016</xref>), is 2-fold higher than that of intact cells (<xref ref-type="fig" rid="F3">Figure 3D</xref>). Obviously, the activity obtained for intact cells does not reflect the maximum BM3 activity available in the cells which corroborates the findings with permeabilized cells and clearly indicates steroid uptake limitation.</p>
</sec>
<sec id="s3-4">
<title>Hydrophobic Outer Membrane Pores Boost Testosterone Hydroxylation by Living Cells</title>
<p>The significant difference between the activities of cell-free extracts, permeabilized, and intact cells indicates that the uptake of testosterone as a large hydrophobic substrate limits its hydroxylation by intact Gram-negative cells. We tested nine different outer membrane proteins for an improvement of testosterone uptake by <italic>E. coli</italic> BL21-Gold(DE3) containing the BM3 variant KSA14m. Candidates were selected from operons that encode pathways enabling growth on or degradation of hydrophobic compounds (<xref ref-type="bibr" rid="B85">Wang et al., 1995</xref>; <xref ref-type="bibr" rid="B1">Ayoubi and Harker, 1998</xref>; <xref ref-type="bibr" rid="B37">Kasai et al., 2001</xref>; <xref ref-type="bibr" rid="B27">Hearn et al., 2008</xref>; <xref ref-type="bibr" rid="B44">Leu et al., 2011</xref>; <xref ref-type="bibr" rid="B40">Kothari et al., 2016</xref>; <xref ref-type="bibr" rid="B49">Mounier et al., 2018</xref>; <xref ref-type="bibr" rid="B56">Olivera and Luengo, 2019</xref>) or based on previous studies employing hydrophobic outer membrane proteins to facilitate hydrophobic substrate uptake (<xref ref-type="bibr" rid="B33">Julsing et al., 2012</xref>; <xref ref-type="bibr" rid="B15">Cornelissen et al., 2013</xref>; <xref ref-type="bibr" rid="B24">Grant et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Call et al., 2016</xref>; <xref ref-type="bibr" rid="B60">Ruff et al., 2016</xref>; <xref ref-type="bibr" rid="B31">Jeon et al., 2018</xref>). Corresponding genes were placed downstream of the <italic>ksa14m</italic> gene in a bicistronic operon (<xref ref-type="sec" rid="s10">Supplementary Figure S1B</xref>).</p>
<p>The co-synthesis of four outer membrane proteins significantly improved the specific whole-cell testosterone hydroxylation activity of living cells. XylN, FhuA &#x394;1-160, and TodX resulted in 3.3-, 4.6-, and 4.9-fold specific activity increases, respectively (<xref ref-type="fig" rid="F4">Figure 4A</xref>). AlkL emerged as the most effective candidate enabling a 5.6-fold increase in whole-cell testosterone hydroxylation activity, corresponding to an even higher protein-specific rate than obtained with KSA14m containing cell-free extract. Induction of heterologous gene expression slightly affected bacterial growth of only the strains carrying <italic>aupA</italic>/<italic>aupB</italic>, <italic>fhuA&#x394;1-160</italic>, <italic>todX</italic>, and <italic>xylN</italic> compared to strains without an additional outer membrane protein (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>). SDS-PAGE analysis of isolated total membrane fractions further confirmed AlkL, FhuA &#x394;1-160, TodX, and XylN synthesis, whereas bands representing the remaining outer membrane proteins were not clearly visible (<xref ref-type="fig" rid="F4">Figure 4B</xref>) which may explain why an effect on whole-cell activity was not observed in these cases. Interestingly, a protein band representing the fatty acid pore FadL was clearly visible, but the respective strain did not show an improved activity. To conclude, whole living cells equipped with hydrophobic outer membrane proteins facilitating testosterone uptake allowed even higher specific turnover rates than obtained with permeabilized cells and cell-free extracts.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Initial specific testosterone hydroxylation activities <bold>(A)</bold> of resting <italic>E. coli</italic> BL21-Gold(DE3) cells carrying pETM11 with <italic>ksa14m</italic> and the genes encoding different membrane proteins after cultivation in M9 medium supplemented with 0.5% (w/v) glucose. Resting cell preparation and activity assays were conducted as described in the Materials and Methods section. Average values and standard deviations of two biological replicates are given. Statistical analysis was performed using Student&#x2019;s <italic>t</italic> test, and the values were taken as significantly different when <italic>p</italic> &#x2264; 0.05. <bold>(B)</bold> SDS-PAGE analysis of total membrane fractions isolated from the respective bacterial strains 5&#xa0;h after induction with 0.1&#xa0;mM IPTG and addition of 0.5&#xa0;mM 5-aminolevulinic acid. Blue arrows point to the protein bands at the sizes expected for the respective membrane proteins.</p>
</caption>
<graphic xlink:href="fctls-02-887458-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Potential of Engineered BM3 Variants for Testosterone Hydroxylation</title>
<p>Incorporation of AlkL into the whole-cell biocatalyst turned out as the most promising strategy to increase whole-cell testosterone hydroxylation activities by a facilitated steroid uptake. Thus, the testosterone hydroxylation capabilities of different BM3 variants were investigated with cells co-expressing <italic>alkL</italic>. Following this strategy, increased whole-cell testosterone hydroxylation rates also were obtained with the variants KSA1, KSA2, KSA3, and KSA14 (<xref ref-type="fig" rid="F5">Figure 5A</xref>) emphasizing the high efficiency, with which these variants can catalyze steroid hydroxylation in living cells. Thereby, AlkL increased specific activities 6- to 28-fold depending on the BM3 variant. Again, bacterial growth was barely affected by additional <italic>alkL</italic> expression (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Cells carrying KSA14m and AlkL emerged as the most active whole-cell biocatalysts and enabled almost complete conversion of 1&#xa0;mM testosterone in the course of 1&#xa0;h as it is shown in <xref ref-type="sec" rid="s10">Supplementary Figure S4</xref>. Substrate depletion appeared to cause a conversion rate decrease towards the end of the biotransformation experiment. Catalyst instability issues possibly caused by inherent enzyme instability and/or substrate/product inhibitions may however also contribute to this effect and will be subject of future research. In conclusion, incorporation of hydrophobic outer membrane proteins, such as AlkL, led to a significant increase of testosterone hydroxylation activities of recombinant <italic>E. coli</italic> cells and thus proved to be a valuable strategy to overcome steroid uptake limitation.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Initial specific testosterone hydroxylation activities <bold>(A)</bold> of resting <italic>E. coli</italic> BL21-Gold(DE3) cells carrying pETM11 with genes encoding different BM3 variants together with or without alkL after 5&#xa0;h of induction in M9 medium supplemented with 0.5%&#xa0;(w/v) glucose. Resting cell preparation and activity assays were performed as described in the Materials and Methods section. <bold>(B)</bold> Specific growth rates of the respective strains in M9 medium upon induction with 0.1&#xa0;mM IPTG and addition of 0.5&#xa0;mM 5-aminolevulinic acid. Average values and standard deviations of two biological replicates are given.</p>
</caption>
<graphic xlink:href="fctls-02-887458-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Biotechnological steroid hydroxylation at industrial scale with the typically employed wildtype microorganisms still suffers from low transformation rates and poor selectivities (<xref ref-type="bibr" rid="B21">Fern&#xe1;ndez-Cabez&#xf3;n et al., 2018</xref>). Steroid-hydroxylating CYP450s are generally characterized by low catalytic turnover rates, the need for electron transfer partners, as well as limitations in the electron transfer from the redox cofactor to the active site (<xref ref-type="bibr" rid="B3">Bernhardt, 2006</xref>; <xref ref-type="bibr" rid="B16">Donova and Egorova, 2012</xref>; <xref ref-type="bibr" rid="B17">Donova, 2017</xref>). These bottlenecks considerably impede the generation of recombinant production strains for commercial applications (<xref ref-type="bibr" rid="B18">Duetz et al., 2001</xref>; <xref ref-type="bibr" rid="B78">van Beilen et al., 2003</xref>; <xref ref-type="bibr" rid="B75">Urlacher and Eiben, 2006</xref>; <xref ref-type="bibr" rid="B32">Julsing et al., 2008</xref>; <xref ref-type="bibr" rid="B2">Bernhardt and Urlacher, 2014</xref>). By engineering the self-sufficient and highly active CYP450 BM3 from <italic>Bacillus megaterium</italic> ATC14581 towards regio- and stereoselective hydroxylation of testosterone, Kille and colleagues laid the foundation for efficient steroid-hydroxylation biocatalysts (<xref ref-type="bibr" rid="B38">Kille et al., 2011</xref>). In this study, we set out to evaluate and improve the applicability of selected BM3 variants in intact living cells as the preferred biocatalyst format for oxygenase-based biocatalysis (<xref ref-type="bibr" rid="B18">Duetz et al., 2001</xref>; <xref ref-type="bibr" rid="B68">Schrewe et al., 2013</xref>) with a focus on increasing the catalytic turnover rates.</p>
<sec id="s4-1">
<title>Introduction of Hydrophobic Outer Membrane Proteins as Promising Strategy to Improve Whole-Cell Steroid Turnover Rates</title>
<p>Former studies demonstrated that hydrophobic substrate uptake across cellular membranes constitutes a major bottleneck in whole-cell biotransformations (<xref ref-type="bibr" rid="B13">Carter et al., 2003</xref>; <xref ref-type="bibr" rid="B23">Fontanille and Larroche, 2003</xref>; <xref ref-type="bibr" rid="B89">Zehentgruber et al., 2010b</xref>; <xref ref-type="bibr" rid="B67">Schrewe et al., 2011</xref>; <xref ref-type="bibr" rid="B24">Grant et al., 2014</xref>). Contrary to small hydrophobic molecules crossing the outer membrane of Gram-negatives through hydrophilic porins and readily diffusing through the cytoplasmic membrane, the uptake of larger hydrophobic molecules is restrained by polar and charged lipopolysaccharides on the cell surface and the hydrophilic nature of porins in the outer membrane (<xref ref-type="bibr" rid="B25">Hancock, 1997</xref>; <xref ref-type="bibr" rid="B53">Nikaido, 2003</xref>). Although strategies targeting membrane destruction or permeabilization may relieve this limitation, they are destructive to the cell and its functionalities and thus not suitable for biocatalytic reactions depending on an active metabolism for cofactor and enzyme regeneration as well as ROS degradation (<xref ref-type="bibr" rid="B32">Julsing et al., 2008</xref>; <xref ref-type="bibr" rid="B33">Julsing et al., 2012</xref>; <xref ref-type="bibr" rid="B68">Schrewe et al., 2013</xref>).</p>
<p>Alternatively, the supply of cells with membrane pores has been established as an approach enabling the conversion of a variety of highly hydrophobic substrates by intact metabolically active cells. <xref ref-type="table" rid="T1">Table 1</xref> shows a comparison of the best results obtained in this study for steroid hydroxylation with those obtained in earlier studies for the conversion of other hydrophobic substrates facilitated by outer membrane proteins. Applied pores range from members of aliphatic and aromatic hydrocarbon degradation pathways to artificially created pores, all with a typically uncharacterized substrate spectrum. In this study, the feasibility of this approach was tested for and extended to steroids. It is clear that such uptake limitation only becomes relevant, if high intracellular steroid conversion activities are established. Our results obtained with the recently published testosterone hydroxylating BM3 variants show that their high activity becomes limited by steroid uptake into intact living cells. The introduction of 4 out of 9 tested outer membrane proteins significantly increased the activity of <italic>E. coli</italic> containing the highly active BM3 variant KSA14m.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Studies reporting enhanced uptake or biotransformation of hydrophobic substrates <italic>via</italic> heterologous outer membrane proteins.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Outer Membrane Protein</th>
<th align="left">Substrate Converting Enzyme</th>
<th align="left">Substrate (MW in g mol<sup>&#x2212;1</sup>)</th>
<th align="left">Impact</th>
<th align="left">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="8" align="left">AlkL (<italic>P. putida&#xa0;</italic>GPo1)</td>
<td rowspan="5" align="left">alkane monooxygenase AlkBGT (<italic>P. putida&#xa0;</italic>GPo1)</td>
<td align="left">n-octane (114)</td>
<td align="left">4-fold increase of specific activity</td>
<td align="left">
<xref ref-type="bibr" rid="B33">Julsing et al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">n-nonane (128)</td>
<td align="left">40-fold increase of specific activity</td>
<td align="left">
<xref ref-type="bibr" rid="B33">Julsing et al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">C<sub>12</sub>-C<sub>16</sub> alkanes (170&#x2013;226)</td>
<td align="left">up to 100-fold increase of specific yields</td>
<td align="left">
<xref ref-type="bibr" rid="B24">Grant et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">nonanoic acid ethyl ester (186)</td>
<td align="left">1.7-fold increase of specific activity</td>
<td align="left">
<xref ref-type="bibr" rid="B82">van Nuland et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">dodecanoic acid methyl ester (214)</td>
<td align="left">28- and 62-fold specific activity increase in single and two-liquid phase systems, respectively</td>
<td align="left">
<xref ref-type="bibr" rid="B33">Julsing et al. (2012)</xref>; <xref ref-type="bibr" rid="B41">Ladkau et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">CYP153A6, Fd, FDR (<italic>Mycobacterium</italic> sp. HXN-1500)</td>
<td align="left">(<italic>S</italic>)-limonene (136)</td>
<td align="left">2- and 5-fold specific activity increase in single and two-liquid phase systems, respectively</td>
<td align="left">
<xref ref-type="bibr" rid="B15">Cornelissen et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">CYP153A, Fd, FDR (<italic>Marinobacterium aquaeolei</italic> VT8)</td>
<td align="left">C<sub>12</sub>-C<sub>16</sub> alkanes (170&#x2013;226)</td>
<td align="left">increased induction caused by alkanes</td>
<td align="left">
<xref ref-type="bibr" rid="B30">Hsieh et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">BM3 variants KSA1, KSA2, KSA3, KSA14, and KSA14m (<italic>B. megaterium</italic> ATCC14581)</td>
<td align="left">testosterone (288)</td>
<td align="left">15-, 20.9-, 28-, 12.6-, and 5.6-fold increase of specific activity</td>
<td align="left">This study</td>
</tr>
<tr>
<td rowspan="4" align="left">FadL (<italic>E. coli</italic> BL21)</td>
<td align="left">hydratase (<italic>Stenotrophomonas maltophilia</italic>)</td>
<td align="left">oleic acid (282)</td>
<td align="left">5.5-fold increase of specific activity</td>
<td align="left">
<xref ref-type="bibr" rid="B31">Jeon et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">ADH (<italic>Micrococcus luteus</italic>)</td>
<td align="left">12- and 10-hydroxy-octadecanoic acid (300)</td>
<td align="left">5.5-fold increase of specific activity</td>
<td align="left">
<xref ref-type="bibr" rid="B31">Jeon et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">ADH (<italic>Micrococcus luteus</italic>), BVMO (<italic>P. putida</italic> KT2440)</td>
<td align="left">ricinoleic acid (298)</td>
<td align="left">2-fold increase of specific activity</td>
<td align="left">
<xref ref-type="bibr" rid="B31">Jeon et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">alkane monooxygenase AlkBGT (<italic>P. putida&#xa0;</italic>GPo1)</td>
<td align="left">n-octane (114)</td>
<td align="left">4.5-fold increase of alkane import rate</td>
<td align="left">
<xref ref-type="bibr" rid="B12">Call et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">FadL (<italic>P. putida</italic> GPo1)</td>
<td align="left">BM3 wildtype (<italic>B. megaterium</italic> ATCC14581)</td>
<td align="left">pentadecanoic acid (242)</td>
<td align="left">up to 2-fold increase of specific activity</td>
<td align="left">
<xref ref-type="bibr" rid="B66">Schneider et al. (1998)</xref>
</td>
</tr>
<tr>
<td rowspan="6" align="left">FhuA &#x394;1-160 (<italic>E. coli</italic>)</td>
<td rowspan="5" align="center">BM3 variants (<italic>B. megaterium</italic> ATCC14581)</td>
<td align="left">toluene (92)</td>
<td align="left">1.5-fold increase of translocation efficiency</td>
<td align="left">
<xref ref-type="bibr" rid="B60">Ruff et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">anisol (108)</td>
<td align="left">1.8-fold increase of translocation efficiency</td>
<td align="left">
<xref ref-type="bibr" rid="B60">Ruff et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">pinene (136)</td>
<td align="left">1.8-fold increase of translocation efficiency</td>
<td align="left">
<xref ref-type="bibr" rid="B60">Ruff et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">limonene (136)</td>
<td align="left">2-fold increase of translocation efficiency</td>
<td align="left">
<xref ref-type="bibr" rid="B60">Ruff et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">7-benzoxy-3-carboxy-coumarin ethyl ester (324)</td>
<td align="left">5-fold increase of translocation efficiency</td>
<td align="left">
<xref ref-type="bibr" rid="B60">Ruff et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">BM3 variant KSA14m</td>
<td align="left">testosterone (288)</td>
<td align="left">4.6-fold increase of specific activity</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">TodX (<italic>P. putida</italic> F1)</td>
<td align="left">BM3 variant KSA14m</td>
<td align="left">testosterone (288)</td>
<td align="left">4.9-fold increase of specific activity</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">XylN (<italic>P. putida</italic> mt-2)</td>
<td align="left">BM3 variant KSA14m</td>
<td align="left">testosterone (288)</td>
<td align="left">3.3-fold increase of specific activity</td>
<td align="left">This study</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Fd, ferredoxin; FDR, ferredoxin reductase; ADH, alcohol dehydrogenase; BVMO, Baeyer-Villiger monooxygenase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>However, the introduction of outer membrane proteins also can be harmful to host cell physiology, either due to metabolic burden of the expression of additional heterologous genes and/or energy demanding, inefficient, and/or improper folding and translocation of membrane proteins (<xref ref-type="bibr" rid="B78">van Beilen et al., 2003</xref>; <xref ref-type="bibr" rid="B35">Kadisch et al., 2017b</xref>). The expression level of pores can be another critical factor as consequentially increased intracellular substrate concentrations may become toxic (<xref ref-type="bibr" rid="B33">Julsing et al., 2012</xref>; <xref ref-type="bibr" rid="B12">Call et al., 2016</xref>; <xref ref-type="bibr" rid="B34">Kadisch et al., 2017a</xref>). For example, biocatalyst destabilization related to high <italic>alkL</italic> expression has been reported during biotransformation of dodecanoic acid methyl ester (<xref ref-type="bibr" rid="B69">Schrewe et al., 2014</xref>) and octane (<xref ref-type="bibr" rid="B24">Grant et al., 2014</xref>). Similar findings have been reported for high level <italic>fadL</italic> expression employed for the conversion of octane (<xref ref-type="bibr" rid="B12">Call et al., 2016</xref>) and (hydroxy) fatty acids (<xref ref-type="bibr" rid="B31">Jeon et al., 2018</xref>). Strains expressing <italic>aupAB</italic>, <italic>fhuA&#x394;1-160</italic>, <italic>todX</italic>, and <italic>xylN</italic> displayed slightly lower specific growth rates compared to a strain harboring only the BM3 variant. Effects on biocatalyst stability remain to be investigated. A fine-tuning of membrane protein expression levels may become necessary to control substrate influx, for example by the use of tightly controlled expression systems (<xref ref-type="bibr" rid="B24">Grant et al., 2014</xref>; <xref ref-type="bibr" rid="B12">Call et al., 2016</xref>), variation of promoter strength (<xref ref-type="bibr" rid="B34">Kadisch et al., 2017a</xref>), or appropriate gene copy number (<xref ref-type="bibr" rid="B31">Jeon et al., 2018</xref>). Furthermore, several technical solutions can be applied to avoid toxic effects of substrate and product molecules, such as the introduction of an organic phase as substrate reservoir and product sink (<xref ref-type="bibr" rid="B78">van Beilen et al., 2003</xref>; <xref ref-type="bibr" rid="B69">Schrewe et al., 2014</xref>).</p>
</sec>
<sec id="s4-2">
<title>Substrate Spectrum of Outer Membrane Proteins</title>
<p>Introduction or overexpression of outer membrane proteins has become an increasingly relevant tool for biotransformations of hydrophobic substrates with whole microbial cells (<xref ref-type="table" rid="T1">Table 1</xref>). Several investigated candidates feature a broad substrate range reaching beyond the natural substrates of the pathways they are associated to. In this study, we report an extension of the so far-known substrate spectrum of several hydrophobic pores towards steroids. Several studies showed that AlkL promotes alkane uptake by <italic>E. coli</italic> (<xref ref-type="bibr" rid="B33">Julsing et al., 2012</xref>; <xref ref-type="bibr" rid="B24">Grant et al., 2014</xref>). This outer membrane protein has been proposed to be structured as an eight-stranded <italic>&#x3b2;</italic>-barrel traversing the lipopolysaccharide layer similar to OmpW of <italic>E. coli</italic>, with which it shares 27% amino acid sequence homology (<xref ref-type="bibr" rid="B77">van Beilen et al., 1992</xref>; <xref ref-type="bibr" rid="B29">Hong et al., 2006</xref>). The extracellular domain has a high affinity for hydrophobic molecules so that substrates are easily channeled across the lipopolysaccharide layer into the hydrophobic interior of AlkL in the outer membrane (<xref ref-type="bibr" rid="B24">Grant et al., 2014</xref>). As for OmpW, the passage is hindered by a narrowing in the channel, which directs molecules to exit through a putative lateral opening into the outer membrane (<xref ref-type="bibr" rid="B29">Hong et al., 2006</xref>). Apparently, this mechanism also works for fatty acid (m)ethyl esters (<xref ref-type="bibr" rid="B33">Julsing et al., 2012</xref>; <xref ref-type="bibr" rid="B41">Ladkau et al., 2016</xref>; <xref ref-type="bibr" rid="B82">van Nuland et al., 2016</xref>) and monoterpenes (<xref ref-type="bibr" rid="B15">Cornelissen et al., 2013</xref>). Interestingly, the radius of the lateral opening (1.3&#xa0;&#xc5;) has been described as incompatible with the size of these known AlkL substrates but has recently been shown to be dynamic due to a continuous restructuring of the barrel dimension and release into the membrane through ephemeral openings (<xref ref-type="bibr" rid="B70">Schubeis et al., 2020</xref>). In this study, AlkL relieved the constrained testosterone uptake into <italic>E. coli</italic> and boosted specific testosterone hydroxylation activities, thus expanding the AlkL substrate spectrum to steroids, which are even larger than the substrates known so far (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>The pivotal role of FadL as a long-chain fatty acid transporter in <italic>E. coli</italic> has already been reported decades ago (<xref ref-type="bibr" rid="B55">Nunn and Simons, 1978</xref>; <xref ref-type="bibr" rid="B5">Black, 1988</xref>). In whole-cell biotransformations of long-chain fatty acids, increased FadL levels significantly improved specific rates (<xref ref-type="bibr" rid="B66">Schneider et al., 1998</xref>; <xref ref-type="bibr" rid="B31">Jeon et al., 2018</xref>). Similar results were obtained for atypical FadL substrates, i.e., long-chain hydroxyl fatty acids (<xref ref-type="bibr" rid="B31">Jeon et al., 2018</xref>). Interestingly, overexpression of <italic>fadL</italic> did not lead to improved steroid hydroxylation rates in this study. Even though the FadL basic structure has been described as similar to AlkL (<xref ref-type="bibr" rid="B81">van den Berg, 2010</xref>), the proposed uptake mechanism differs significantly. FadL is described as a long barrel composed of 14 antiparallel <italic>&#x3b2;</italic>-strands that is plugged by a central hatch domain and possesses an opening based on an inward-pointing kink in one of the <italic>&#x3b2;</italic>-strands (<xref ref-type="bibr" rid="B79">van den Berg et al., 2004</xref>). Between two extracellular loops, a hydrophobic groove comprises a low-affinity binding site for substrates, which then diffuse into a high-affinity binding pocket inside the barrel close the N-terminus. Conformational changes in the N-terminus and the hatch result in an affinity decrease and generate a lateral channel for the substrate to move into the outer membrane (<xref ref-type="bibr" rid="B28">Hearn et al., 2009</xref>; <xref ref-type="bibr" rid="B81">van den Berg, 2010</xref>). Thereby, substrate binding has been suggested as prerequisite (<xref ref-type="bibr" rid="B4">Black and Zhang, 1995</xref>; <xref ref-type="bibr" rid="B43">Lepore et al., 2011</xref>), with the affinity strongly varying with fatty acid chain length (<xref ref-type="bibr" rid="B6">Black, 1990</xref>) and long-chain fatty acids (&#x2265;C<sub>12</sub>) being preferred over mid-chain fatty acids (C<sub>8</sub>-C<sub>11</sub>) (<xref ref-type="bibr" rid="B47">Maloy et al., 1981</xref>; <xref ref-type="bibr" rid="B6">Black, 1990</xref>). Generally, electrostatic forces between negatively charged carboxyl groups and positively charged amino acid residues within the FadL binding pocket have been considered necessary for substrate binding (<xref ref-type="bibr" rid="B80">van den Berg, 2005</xref>), which would exclude non-charged compounds as FadL substrates. The variation of FadL expression levels however was recently shown to modulate the import of medium-chain alkanes into <italic>E. coli</italic> (<xref ref-type="bibr" rid="B12">Call et al., 2016</xref>), suggesting that substrate binding is not necessarily charge-dependent. The missing facilitation of steroid import by FadL observed in this study is in line with a possible charge dependency and/or a rather confined substrate specificity.</p>
<p>In contrast, truncated FhuA was found to facilitate testosterone uptake. The native, complete protein is responsible for the active import of ferric hydroxamate into <italic>E. coli</italic>. Removal of the first 160&#xa0;amino acids (N-terminal cork domain) converted the active iron transporter into a large passive diffusion channel (i.e., FhuA &#x394;1-160) differing from AlkL in terms of uptake mechanism (<xref ref-type="bibr" rid="B60">Ruff et al., 2016</xref>). FhuA &#x394;1-160 has been shown to improve the uptake of terpenes and aromatic compounds into <italic>E. coli</italic> up to 5-fold (<xref ref-type="bibr" rid="B60">Ruff et al., 2016</xref>). It also was found to facilitate testosterone uptake resulting in a 4.6-fold specific whole-cell activity increase, and thus can be considered a valuable outer membrane protein with a broad substrate spectrum.</p>
<p>Among the putative hydrophobic substrate uptake pores from hydrocarbon-degrading bacteria, TodX from <italic>P. putida</italic> F1 and XylN from <italic>P. putida</italic> mt-2 were found to significantly enhance whole-cell testosterone hydroxylation. Both have been reported to be involved in the uptake of alkylaromatic compounds such as toluene or xylene (<xref ref-type="bibr" rid="B85">Wang et al., 1995</xref>; <xref ref-type="bibr" rid="B37">Kasai et al., 2001</xref>). Interestingly, they share sequence homology with each other and further putative outer membrane proteins from hydrocarbon-degrading Gram-negative bacteria, e.g., TbuX, CymD, PorA, and CumH (<xref ref-type="bibr" rid="B36">Kahng et al., 2000</xref>; <xref ref-type="bibr" rid="B37">Kasai et al., 2001</xref>; <xref ref-type="bibr" rid="B27">Hearn et al., 2008</xref>), which thus also constitute interesting candidates for the enhancement of hydrophobic substrate uptake.</p>
<p>Few bacteria have been reported to be capable of metabolizing steroids, which generally are considered as highly biodegradation-resistant. Known uptake systems mostly do not involve only one, but a set of proteins (<xref ref-type="bibr" rid="B56">Olivera and Luengo, 2019</xref>), e.g., ten ATP-dependent proteins encoded in the actinobacterial <italic>mce4</italic> locus (<xref ref-type="bibr" rid="B48">Mohn et al., 2008</xref>). A putative, but not yet characterized Major Facilitator Superfamily Transporter (MFS) originating from the testosterone-degrading strain <italic>Comamonas thiooxydans</italic> (NCBI Reference Sequence WP_041743963) did not increase testosterone hydroxylation rates. While AupA and AupB have been described as outer and inner membrane proteins, respectively, involved in alkane uptake in <italic>Marinobacter hydrocarbonoclasticus</italic> SP17 (<xref ref-type="bibr" rid="B49">Mounier et al., 2018</xref>), the exact function of proteins encoded by ORF664 and ORF665 in <italic>Acinetobacter venetianus</italic> RAG-1 is currently uncertain, with a possible role in dodecane uptake (<xref ref-type="bibr" rid="B40">Kothari et al., 2016</xref>). Besides an unsuitable substrate specificity, expression issues such as improper folding may be the reason for the lacking positive effect on testosterone hydroxylation in these cases.</p>
<p>The increase in testosterone hydroxylation activities not only depended on the type of outer membrane protein applied, but, interestingly, also deferred for different BM3 variants applying the same pore. This high variation may be due to differing K<sub>m</sub> values of respective BM3 variants. For example, the K<sub>m</sub> of KSA2 for testosterone has been reported to be 86-times higher than the K<sub>m</sub> of KSA14 (<xref ref-type="bibr" rid="B38">Kille et al., 2011</xref>). Such a high K<sub>m</sub> may increase the substrate limitation effect without AlkL. The impact of facilitated substrate uptake <italic>via</italic> an outer membrane protein thus would be much higher as it was the case for KSA2 as compared to KSA14 in combination with AlkL (<xref ref-type="fig" rid="F5">Figure 5A</xref>).</p>
</sec>
<sec id="s4-3">
<title>Benchmarking BM3-Catalyzed Testosterone Hydroxylation in the Whole-Cell Biocatalyst Format</title>
<p>In this study, we investigated the steroid hydroxylation performance of highly active BM3 variants in living <italic>E. coli</italic> cells equipped with different hydrophobic outer membrane proteins to relieve substrate uptake limitation. <italic>In vivo</italic> testosterone hydroxylation rates obtained with these whole-cell biocatalysts even exceeded activities obtained with permeabilized cells or cell-free extracts (for KSA14m), which can be ascribed to the stabilizing cellular environment and efficient cell-, enzyme-, and cofactor regeneration qualifying such whole-cell biocatalysts for successful future bioprocess development (<xref ref-type="bibr" rid="B18">Duetz et al., 2001</xref>; <xref ref-type="bibr" rid="B78">van Beilen et al., 2003</xref>; <xref ref-type="bibr" rid="B87">Woodley, 2006</xref>; <xref ref-type="bibr" rid="B68">Schrewe et al., 2013</xref>). During the past decades, many CYP450s with diverse specificities have been described and engineered for steroid hydroxylations (<xref ref-type="bibr" rid="B11">Bureik and Bernhardt, 2007</xref>; <xref ref-type="bibr" rid="B16">Donova and Egorova, 2012</xref>; <xref ref-type="bibr" rid="B73">Szaleniec et al., 2018</xref>; <xref ref-type="bibr" rid="B90">Zhang et al., 2020</xref>), with the discovery of novel products and selectivity improvement as main arguments for high industrial potential (<xref ref-type="bibr" rid="B22">Fernandes et al., 2003</xref>; <xref ref-type="bibr" rid="B90">Zhang et al., 2020</xref>). However, only few studies went beyond typical screening experiments towards the evaluation of biocatalytic performance in terms of final product titer, volumetric productivity, and maximum specific activity. An overview of the latter is given in <xref ref-type="table" rid="T2">Table 2</xref> based on data provided in references and estimations derived therefrom. The summarized studies differ in employed CYP450 and desired hydroxylation as well as applied redox partner proteins, host organism, and biocatalyst format.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>CYP450-catalyzed steroid hydroxylation efficiencies.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Enzyme</th>
<th align="left">Redox Partners</th>
<th align="left">Host and Biocatalyst Format</th>
<th align="left">Reaction</th>
<th align="left">Reac-tion Time</th>
<th align="left">Product Titer [mg L<sup>&#x2212;1</sup>]</th>
<th align="left">Volumetric Productivity [mg L<sup>&#x2212;1</sup>&#xa0;h<sup>&#x2212;1</sup>]</th>
<th align="left">Maximum Specific Activity</th>
<th align="left">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">CYP21 (human)</td>
<td align="left">CYP450 reductase (endogenous)</td>
<td align="left">
<italic>Schizosaccharomyces pombe</italic> CAD 18 (permeabilized cells)</td>
<td align="left">21-hydroxylation of 17&#x3b1;-hydroxy-progesterone</td>
<td align="center">10&#xa0;h</td>
<td align="center">78<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">7.8<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">0.05&#xa0;U g<sub>WCW</sub>
<sup>&#x2212;1</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B88">Zehentgruber et al. (2010a)</xref>
</td>
</tr>
<tr>
<td align="left">CYP3A4 (human)</td>
<td align="left">CYP450 reductase (human)</td>
<td align="left">
<italic>Yarrowia lipolytica</italic> H222-S4 (resting cells)</td>
<td align="left">6&#x3b2;-hydroxylation of progesterone</td>
<td align="center">90&#xa0;h</td>
<td align="center">76<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">0.84<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">0.02&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup>
</td>
<td align="left">
<xref ref-type="bibr" rid="B8">Braun et al. (2012)</xref>
</td>
</tr>
<tr>
<td align="left">CYP11B1 G23R_L271M (human)</td>
<td align="left">Ad, ADR (bovine)</td>
<td align="left">
<italic>E. coli</italic> C43(DE3) (resting cells)</td>
<td align="left">11&#x3b2;-hydroxylation of 11-deoxycortisol</td>
<td align="center">24&#xa0;h</td>
<td align="center">843</td>
<td align="center">35</td>
<td align="left">0.09&#xa0;U g<sub>WCW</sub>
<sup>&#x2212;1</sup> (first 12&#xa0;h)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B63">Schiffer et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">CYP21A2 (bovine)</td>
<td align="left">Fd, ADR (<italic>S. pombe</italic>)</td>
<td align="left">
<italic>E. coli</italic> C43(DE3) (resting cells)</td>
<td align="left">21-hydroxylation of medrane</td>
<td align="center">20&#xa0;h</td>
<td align="center">650</td>
<td align="center">27</td>
<td align="left">0.06&#xa0;U g<sub>WCW</sub>
<sup>&#x2212;1</sup> (first 3&#xa0;h)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B9">Brixius-Anderko et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">CYP21A2 M210V (bovine)</td>
<td align="left">truncated CYP450 reductase (bovine)</td>
<td align="left">
<italic>E. coli</italic> C43(DE3) (permeabilized cells)</td>
<td align="left">21-hydroxylation of medrane</td>
<td align="center">24&#xa0;h</td>
<td align="center">691</td>
<td align="center">29</td>
<td align="left">0.01&#xa0;U g<sub>WCW</sub>
<sup>&#x2212;1</sup> (24&#xa0;h)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B39">K&#xf6;nig et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">CYP106A2 (<italic>B. megaterium</italic>)</td>
<td align="left">Ad, ADR (bovine)</td>
<td align="left">
<italic>E. coli</italic> JM109 (growing cells)</td>
<td align="left">15&#x3b2;-hydroxylation of 11-deoxy-corticosterone</td>
<td align="center">48&#xa0;h</td>
<td align="center">330 (theo-retical)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">14 (theo-retical)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">OD or biomass conc. not given</td>
<td align="left">
<xref ref-type="bibr" rid="B26">Hannemann et al. (2006)</xref>
</td>
</tr>
<tr>
<td align="left">CYP106A2 (<italic>B. megaterium</italic>)</td>
<td align="left">Ad, ADR (bovine)</td>
<td align="left">
<italic>E. coli</italic> BL21 (lyophilized cell extract)</td>
<td align="left">15&#x3b2;-hydroxylation of progesterone</td>
<td align="center">45&#xa0;min</td>
<td align="center">121<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">154 (theoretical)</td>
<td align="left">2&#xa0;U g<sub>WCW</sub>
<sup>&#x2212;1</sup> (first 5&#xa0;min)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B89">Zehentgruber et al. (2010b)</xref>
</td>
</tr>
<tr>
<td align="left">CYP106A2 (<italic>B. megaterium</italic>)</td>
<td align="left">Ad, ADR (bovine)</td>
<td align="left">
<italic>E. coli</italic> BL21 (lyophilized cell extract)</td>
<td align="left">15&#x3b2;-hydroxylation of testosterone</td>
<td align="center">30&#xa0;min</td>
<td align="center">115<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">229 (theoretical)</td>
<td align="left">1.08&#xa0;U g<sub>WCW</sub>
<sup>&#x2212;1</sup> (first 7&#xa0;min)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B89">Zehentgruber et al. (2010b)</xref>
</td>
</tr>
<tr>
<td align="left">CYP106A2 (<italic>B. megaterium</italic>)</td>
<td align="left">truncated Ad, ADR (bovine)</td>
<td align="left">
<italic>Bacillus megaterium</italic> MS941 (resting cells)</td>
<td align="left">7&#x3b2;-hydroxylation of dehydroepiandro-sterone</td>
<td align="center">24&#xa0;h</td>
<td align="center">2,470<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">103</td>
<td align="left">0.14&#xa0;U g<sub>WCW</sub>
<sup>&#x2212;1</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B65">Schmitz et al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">CYP109B1 (<italic>B. subtilis</italic> 168)</td>
<td align="left">Fd, FDR (<italic>Synechococcus elongates</italic>)</td>
<td align="left">
<italic>E. coli</italic> BL21(DE3) (permeabilized cells)</td>
<td align="left">15&#x3b2;-hydroxylation of testosterone</td>
<td align="center">20&#xa0;h</td>
<td align="center">235<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">12<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">0.10&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B91">Zhang et al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">CYP109E1(<italic>B. megaterium</italic>)</td>
<td align="left">truncated Ad, ADR (bovine)</td>
<td align="left">
<italic>E. coli</italic> C43(DE3) (permeabilized cells)</td>
<td align="left">24- and 25-monohydroxylation of cholesterol</td>
<td align="center">48&#xa0;h</td>
<td align="center">1<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">45</td>
<td align="left">0.01&#xa0;U g<sub>cells</sub>
<sup>&#x2212;1</sup> (first 4&#xa0;h)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B59">Putkaradze et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">CYP154C5 (<italic>Nocardia farcinica</italic>)</td>
<td align="left">Pd, PDR (<italic>P. putida</italic>)</td>
<td align="left">
<italic>E. coli</italic> C43(DE3) (resting cells)</td>
<td align="left">16&#x3b1;-hydroxylation of pregnenolone</td>
<td align="center">6&#xa0;h</td>
<td align="center">633<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">106<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">0.31&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> (first 120&#xa0;min)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn4">
<sup>d</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B7">Bracco et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">CYP154C5 (<italic>Nocardia farcinica</italic>)</td>
<td align="left">Pd, PDR (<italic>P. putida</italic>)</td>
<td align="left">
<italic>E. coli</italic> C43(DE3) (resting cells)</td>
<td align="left">16&#x3b1;-hydroxylation of progesterone</td>
<td align="center">4&#xa0;h</td>
<td align="center">629<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">167<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">0.86&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> (first 1&#xa0;h)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn4">
<sup>d</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B7">Bracco et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">CYP154C5 (<italic>Nocardia farcinica</italic>)</td>
<td align="left">Pd, PDR (<italic>P. putida</italic>)</td>
<td align="left">
<italic>E. coli</italic> C43(DE3) (resting cells)</td>
<td align="left">16&#x3b1;-hydroxylation of testosterone</td>
<td align="center">8&#xa0;h</td>
<td align="center">289<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">36<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">0.17&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> (first 1&#xa0;h)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup>
<xref ref-type="table-fn" rid="Tfn4">
<sup>d</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B7">Bracco et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">CYP260A1 T224A (<italic>Sorangium cellulosum</italic>)</td>
<td align="left">truncated Ad, ADR (bovine)</td>
<td align="left">
<italic>E. coli</italic> C43(DE3) (growing cells)</td>
<td align="left">9&#x3b1;-hydroxylation of 11-deoxycortisone</td>
<td align="center">24&#xa0;h</td>
<td align="center">250</td>
<td align="center">10</td>
<td align="left">OD or biomass conc. not given</td>
<td align="left">
<xref ref-type="bibr" rid="B46">Litzenburger and Bernhardt, (2017)</xref>
</td>
</tr>
<tr>
<td align="left">CYP102A1 (BM3) variant M02</td>
<td align="left">-</td>
<td align="left">
<italic>Rhodococcus erythropolis</italic> RG9 (growing cells)</td>
<td align="left">16&#x3b2;-hydroxylation of norandrostane-dione</td>
<td align="center">20&#xa0;h</td>
<td align="center">350</td>
<td align="center">18</td>
<td align="left">biomass concentration not deducible</td>
<td align="left">
<xref ref-type="bibr" rid="B84">Venkataraman et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="left">BM3 variant LG-23</td>
<td align="left">-</td>
<td align="left">
<italic>E. coli</italic> BL21(DE3) (permeabilized cells)</td>
<td align="left">7&#x3b2;-hydroxylation of testosterone</td>
<td align="center">5&#xa0;h</td>
<td align="center">271<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">54<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">OD or biomass conc. not given</td>
<td align="left">
<xref ref-type="bibr" rid="B45">Li et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">BM3 variant LG-23/T438S</td>
<td align="left">-</td>
<td align="left">
<italic>E. coli</italic> BL21(DE3) (permeabilized cells)</td>
<td align="left">11&#x3b1;-hydroxylation of estra-4,9-diene-3,17-dione</td>
<td align="center">5&#xa0;h</td>
<td align="center">267<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="center">53<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">0.19&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</td>
<td align="left">
<xref ref-type="bibr" rid="B58">Peng et al. (2022)</xref>
</td>
</tr>
<tr>
<td align="left">BM3 variant KSA1</td>
<td align="left">-</td>
<td align="left">
<italic>E. coli</italic> BL21-Gold(DE3) (resting cells with AlkL)</td>
<td align="left">2&#x3b2;-hydroxylation of testosterone</td>
<td align="center">1&#xa0;h</td>
<td align="center">164</td>
<td align="center">164</td>
<td align="left">14.6&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> (first 10&#xa0;min)</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">BM3 variant KSA2</td>
<td align="left">-</td>
<td align="left">
<italic>E. coli</italic> BL21-Gold(DE3) (resting cells with AlkL)</td>
<td align="left">2&#x3b2;-hydroxylation of testosterone</td>
<td align="center">1&#xa0;h</td>
<td align="center">61</td>
<td align="center">61</td>
<td align="left">8.78&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> (first 10&#xa0;min)</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">BM3 variant KSA3</td>
<td align="left">-</td>
<td align="left">
<italic>E. coli</italic> BL21-Gold(DE3) (resting cells with AlkL)</td>
<td align="left">2&#x3b2;-hydroxylation of testosterone</td>
<td align="center">1&#xa0;h</td>
<td align="center">41</td>
<td align="center">41</td>
<td align="left">7.19&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> (first 10&#xa0;min)</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">BM3 variant KSA14</td>
<td align="left">-</td>
<td align="left">
<italic>E. coli</italic> BL21-Gold(DE3) (resting cells with AlkL)</td>
<td align="left">15&#x3b2;-hydroxylation of testosterone</td>
<td align="center">1&#xa0;h</td>
<td align="center">123</td>
<td align="center">123</td>
<td align="left">13.4&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> (first 10&#xa0;min)</td>
<td align="left">This study</td>
</tr>
<tr>
<td align="left">BM3 variant KSA14m</td>
<td align="left">-</td>
<td align="left">
<italic>E. coli</italic> BL21-Gold(DE3) (resting cells with AlkL)</td>
<td align="left">15&#x3b2;-hydroxylation of testosterone</td>
<td align="center">1&#xa0;h</td>
<td align="center">195</td>
<td align="center">195</td>
<td align="left">34.4&#xa0;U g<sub>CDW</sub>
<sup>&#x2212;1</sup> (first 10&#xa0;min)</td>
<td align="left">This study</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Fd, ferredoxin; FDR, ferredoxin reductase, Ad, adrenodoxin; ADR, adrenodoxin reductase; Pd, putidaredoxin, PDR, putidaredoxin reductase.</p>
</fn>
<fn id="Tfn1">
<label>a</label>
<p>Estimated from figures and parameters (conversions, selectivities, biocatalyst concentrations) provided by the respective reference.</p>
</fn>
<fn id="Tfn2">
<label>b</label>
<p>WCW: wet cell weight.</p>
</fn>
<fn id="Tfn3">
<label>c</label>
<p>CDW, calculated based on given OD<sub>600</sub> &#x3d; 20 and empirical correlation factor 0.34 for <italic>E. coli</italic> (&#x3d; 6.8&#xa0;g<sub>CDW</sub> L<sup>&#x2212;1</sup>) (<xref ref-type="bibr" rid="B19">Falcioni et al., 2013</xref>).</p>
</fn>
<fn id="Tfn4">
<label>d</label>
<p>CDW, calculated based on given OD<sub>600</sub> &#x3d; 40 and empirical correlation factor 0.34 for <italic>E. coli</italic> (&#x3d; 13.6&#xa0;g<sub>CDW</sub> L<sup>&#x2212;1</sup>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Some reported final product titers exceed the minimum process requirements of 0.001 and 0.1&#xa0;g L<sup>&#x2212;1</sup> h<sup>&#x2212;1</sup> for pharmaceuticals and fine chemicals, respectively (<xref ref-type="bibr" rid="B72">Straathof et al., 2002</xref>). Mammalian CYP450s provided the least promising results (<xref ref-type="bibr" rid="B88">Zehentgruber et al., 2010a</xref>; <xref ref-type="bibr" rid="B8">Braun et al., 2012</xref>; <xref ref-type="bibr" rid="B9">Brixius-Anderko et al., 2015</xref>; <xref ref-type="bibr" rid="B63">Schiffer et al., 2015</xref>; <xref ref-type="bibr" rid="B39">K&#xf6;nig et al., 2020</xref>) as expected based on their discussed drawbacks for biotechnological use (<xref ref-type="bibr" rid="B3">Bernhardt, 2006</xref>; <xref ref-type="bibr" rid="B76">Urlacher and Schmid, 2006</xref>). With bacterial CYP450s generally acknowledged as more favorable, recent research has focused especially on the families CYP106, CYP154, CYP109, and CYP260 (<xref ref-type="bibr" rid="B73">Szaleniec et al., 2018</xref>). Comparable with mammalian CYP450s, good steroid hydroxylation efficiencies were not reported for wildtype CYP109 and CYP260 or their variants in the chosen setups (<xref ref-type="bibr" rid="B46">Litzenburger and Bernhardt, 2017</xref>; <xref ref-type="bibr" rid="B59">Putkaradze et al., 2019</xref>; <xref ref-type="bibr" rid="B91">Zhang et al., 2021</xref>). In contrast, CYP106A2 and CYP154C5 enabled ca. 10-fold higher final product titers (<xref ref-type="bibr" rid="B26">Hannemann et al., 2006</xref>; <xref ref-type="bibr" rid="B89">Zehentgruber et al., 2010b</xref>; <xref ref-type="bibr" rid="B7">Bracco et al., 2013</xref>; <xref ref-type="bibr" rid="B65">Schmitz et al., 2014</xref>). Final product titers in the same range have also been reported for BM3 variants engineered for steroid hydroxylation with differing regiospecificities (<xref ref-type="bibr" rid="B84">Venkataraman et al., 2015</xref>; <xref ref-type="bibr" rid="B45">Li et al., 2020</xref>; <xref ref-type="bibr" rid="B58">Peng et al., 2022</xref>). In the present study, such product titers were reached in a shorter period of time and with lower whole-cell biocatalyst concentrations. This was enabled by specific activities exceeding the so far reported values by factors of 8 up to 40 compared with the turnover rates of progesterone hydroxylation by Bracco and coworkers (<xref ref-type="bibr" rid="B7">Bracco et al., 2013</xref>), emphasizing the great potential of these BM3 variants in whole cells equipped with hydrophobic outer membrane pores such as AlkL for steroid hydroxylation. For high volumetric productivities and product titers, extended reaction times and high biomass concentrations are prerequisites and promise highly efficient steroid hydroxylation with the hydrophobic pore-containing whole-cell biocatalysts developed in this study.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In this study, we highlight whole-cell biocatalysts as preferable format for testosterone hydroxylation. The application of a highly active steroid-hydroxylating CYP450 such as the BM3 variant KSA14m and a suitable hydrophobic outer membrane protein such as AlkL brings whole-cell steroid hydroxylation activities to a new level (an up to 40-fold increase) with the potential to boost productivities and product titers of microbial steroid conversion processes. Furthermore, this study highlights the broad substrate spectrum of several hydrophobic outer membrane proteins and thus also contributes to the improvement of whole-cell bioconversions of hydrophobic substrates in general. Following studies will assess stability and kinetics of the constructed whole-cell biocatalysts aiming at their highly productive application on bioreactor scale.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>CB, MM, RK, AS, and BB were involved in the conception and design of the study. CB and MM performed experimental work and collected data. CB, MM, and BB did data curation and interpretation. CB wrote the original draft of the manuscript. BB contributed in terms of article structuring and editing. All authors were involved in final editing and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors thank Bayer AG for financial support. We further acknowledge the use of the facilities of the Centre for Biocatalysis (MiKat) at the Helmholtz Centre for Environmental Research, which is supported by the European Regional Development Funds (EFRE, Europe founds Saxony) and the Helmholtz Association.</p>
</ack>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fctls.2022.887458/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fctls.2022.887458/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet1.docx" id="SM2" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayoubi</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Harker</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Whole-cell Kinetics of Trichloroethylene Degradation by Phenol Hydroxylase in a <italic>Ralstonia eutropha</italic> JMP134 Derivative</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>64</volume> (<issue>11</issue>), <fpage>4353</fpage>&#x2013;<lpage>4356</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.64.11.4353-4356.1998</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Urlacher</surname>
<given-names>V. B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Cytochromes P450 as Promising Catalysts for Biotechnological Application: Chances and Limitations</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>98</volume> (<issue>14</issue>), <fpage>6185</fpage>&#x2013;<lpage>6203</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-014-5767-7</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Cytochromes P450 as Versatile Biocatalysts</article-title>. <source>J. Biotechnol.</source> <volume>124</volume> (<issue>1</issue>), <fpage>128</fpage>&#x2013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2006.01.026</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Black</surname>
<given-names>P. N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Evidence that His<sup>110</sup> of the Protein FadL in the Outer Membrane of <italic>Escherichia coli</italic> Is Involved in the Binding and Uptake of Long-Chain Fatty Acids: Possible Role of This Residue in Carboxylate Binding</article-title>. <source>Biochem. J.</source> <volume>310</volume>, <fpage>389</fpage>&#x2013;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1042/bj3100389</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Black</surname>
<given-names>P. N.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>The <italic>fadL</italic> Gene Product of <italic>Escherichia coli</italic> Is an Outer Membrane Protein Required for Uptake of Long-Chain Fatty Acids and Involved in Sensitivity to Bacteriophage T2</article-title>. <source>J. Bacteriol.</source> <volume>170</volume> (<issue>6</issue>), <fpage>2850</fpage>&#x2013;<lpage>2854</lpage>. <pub-id pub-id-type="doi">10.1128/jb.170.6.2850-2854.1988</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Black</surname>
<given-names>P. N.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Characterization of FadL-specific Fatty Acid Binding in <italic>Escherichia coli</italic>
</article-title>. <source>Biochim. Biophys. Acta (Bba) - Lipids Lipid Metab.</source> <volume>1046</volume> (<issue>1</issue>), <fpage>97</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2760(90)90099-j</pub-id> </citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blank</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>B&#x00FC;hler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Metabolic Capacity Estimation of <italic>Escherichia coli</italic> as a Platform for Redox Biocatalysis: Constraint-Based Modeling and Experimental Verification</article-title>. <source>Biotechnol. Bioeng</source> <volume>100</volume> (<issue>6</issue>), <fpage>1050</fpage>&#x2013;<lpage>1065</lpage>. <pub-id pub-id-type="doi">10.1002/bit.21837</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bracco</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Schallmey</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Selective Steroid Oxyfunctionalisation by CYP154C5, a Bacterial Cytochrome P450</article-title>. <source>Microb. Cel. Fact.</source> <volume>12</volume>, <fpage>95</fpage>. <pub-id pub-id-type="doi">10.1186/1475-2859-12-95</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braun</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Geier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mauersberger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Glieder</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Steroid Biotransformations in Biphasic Systems with <italic>Yarrowia lipolytica</italic> Expressing Human Liver Cytochrome P450 Genes</article-title>. <source>Microb. Cel. Fact.</source> <volume>11</volume>, <fpage>106</fpage>. <pub-id pub-id-type="doi">10.1186/1475-2859-11-106</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brixius-Anderko</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schiffer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hannemann</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Janocha</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>A CYP21A2 Based Whole-Cell System in <italic>Escherichia coli</italic> for the Biotechnological Production of Premedrol</article-title>. <source>Microb. Cel. Fact.</source> <volume>14</volume>, <fpage>135</fpage>. <pub-id pub-id-type="doi">10.1186/s12934-015-0333-2</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bu&#x308;hler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.-B.</given-names>
</name>
<name>
<surname>Blank</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>NADH Availability Limits Asymmetric Biocatalytic Epoxidation in a Growing Recombinant <italic>Escherichia coli</italic> Strain</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>74</volume> (<issue>5</issue>), <fpage>1436</fpage>&#x2013;<lpage>1446</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02234-07</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Bureik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2007</year>). &#x201c;<article-title>Steroid Hydroxylation: Microbial Steroid Biotransformations Using Cytochrome P450 Enzymes</article-title>,&#x201d; in <source>Modern Biooxidation. Enzymes, Reactions and Applications</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Schmid</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Urlacher</surname>
<given-names>V. B.</given-names>
</name>
</person-group> (<publisher-loc>Weinheim</publisher-loc>: <publisher-name>WILEY-VCH Verlag GmbH &#x26; Co. KGaA</publisher-name>), <fpage>155</fpage>&#x2013;<lpage>176</lpage>. </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Call</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Baganz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Modulating the Import of Medium-Chain Alkanes in <italic>E. coli</italic> through Tuned Expression of FadL</article-title>. <source>J. Biol. Eng.</source> <volume>10</volume>, <fpage>5</fpage>. <pub-id pub-id-type="doi">10.1186/s13036-016-0026-3</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Croteau</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Monoterpene Biosynthesis Pathway Construction in <italic>Escherichia coli</italic>
</article-title>. <source>Phytochemistry</source> <volume>64</volume> (<issue>2</issue>), <fpage>425</fpage>&#x2013;<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1016/s0031-9422(03)00204-8</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>R. R.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Permeability Issues in Whole-Cell Bioprocesses and Cellular Membrane Engineering</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>74</volume> (<issue>4</issue>), <fpage>730</fpage>&#x2013;<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-006-0811-x</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cornelissen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Julsing</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Volmer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Riechert</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Whole-cell-based CYP153A6-Catalyzed (<italic>S</italic>)-limonene Hydroxylation Efficiency Depends on Host Background and Profits from Monoterpene Uptake via AlkL</article-title>. <source>Biotechnol. Bioeng.</source> <volume>110</volume> (<issue>5</issue>), <fpage>1282</fpage>&#x2013;<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1002/bit.24801</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donova</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Egorova</surname>
<given-names>O. V.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Microbial Steroid Transformations: Current State and Prospects</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>94</volume> (<issue>6</issue>), <fpage>1423</fpage>&#x2013;<lpage>1447</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-012-4078-0</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donova</surname>
<given-names>M. V.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Steroid Bioconversions</article-title>. <source>Methods Mol. Biol.</source> <volume>1645</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-7183-1_1</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duetz</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>van Beilen</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Witholt</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Using Proteins in Their Natural Environment: Potential and Limitations of Microbial Whole-Cell Hydroxylations in Applied Biocatalysis</article-title>. <source>Curr. Opin. Biotechnol.</source> <volume>12</volume> (<issue>4</issue>), <fpage>419</fpage>&#x2013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1016/s0958-1669(00)00237-8</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falcioni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Blank</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Frick</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Karau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Proline Availability Regulates Proline-4-Hydroxylase Synthesis and Substrate Uptake in Proline-Hydroxylating Recombinant <italic>Escherichia coli</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>79</volume> (<issue>9</issue>), <fpage>3091</fpage>&#x2013;<lpage>3100</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.03640-12</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Felix</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>Permeabilized Cells</article-title>. <source>Anal. Biochem.</source> <volume>120</volume> (<issue>2</issue>), <fpage>211</fpage>&#x2013;<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1016/0003-2697(82)90340-2</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fern&#xe1;ndez-Cabez&#xf3;n</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gal&#xe1;n</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Garc&#xed;a</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>New Insights on Steroid Biotechnology</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>, <fpage>958</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.00958</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cruz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Angelova</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pinheiro</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Cabral</surname>
<given-names>J. M. S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Microbial Conversion of Steroid Compounds: Recent Developments</article-title>. <source>Enzyme Microb. Technol.</source> <volume>32</volume> (<issue>6</issue>), <fpage>688</fpage>&#x2013;<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1016/S0141-0229(03)00029-2</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontanille</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Larroche</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Optimization of Isonovalal Production from &#x3b1;-pinene Oxide Using Permeabilized Cells of <italic>Pseudomonas rhodesiae</italic> CIP 107491</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>60</volume> (<issue>5</issue>), <fpage>534</fpage>&#x2013;<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-002-1164-8</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grant</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Deszcz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Torres</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Folliard</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Identification and Use of an Alkane Transporter Plug-In for Applications in Biocatalysis and Whole-Cell Biosensing of Alkanes</article-title>. <source>Sci. Rep.</source> <volume>4</volume>, <fpage>5844</fpage>. <pub-id pub-id-type="doi">10.1038/srep05844</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hancock</surname>
<given-names>R. E. W.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>The Bacterial Outer Membrane as a Drug Barrier</article-title>. <source>Trends Microbiol.</source> <volume>5</volume> (<issue>1</issue>), <fpage>37</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/S0966-842X(97)81773-8</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannemann</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Virus</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Design of an <italic>Escherichia coli</italic> System for Whole Cell Mediated Steroid Synthesis and Molecular Evolution of Steroid Hydroxylases</article-title>. <source>J. Biotechnol.</source> <volume>124</volume> (<issue>1</issue>), <fpage>172</fpage>&#x2013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2006.01.009</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hearn</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Outer-membrane Transport of Aromatic Hydrocarbons as a First Step in Biodegradation</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>105</volume> (<issue>25</issue>), <fpage>8601</fpage>&#x2013;<lpage>8606</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0801264105</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hearn</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Lepore</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Indic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Transmembrane Passage of Hydrophobic Compounds through a Protein Channel wall</article-title>. <source>Nature</source> <volume>458</volume> (<issue>7236</issue>), <fpage>367</fpage>&#x2013;<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1038/nature07678</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Tamm</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The Outer Membrane Protein OmpW Forms an Eight-Stranded &#x3b2;-barrel with a Hydrophobic Channel</article-title>. <source>J. Biol. Chem.</source> <volume>281</volume> (<issue>11</issue>), <fpage>7568</fpage>&#x2013;<lpage>7577</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M512365200</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.-T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Production of 1-dodecanol, 1-tetradecanol, and 1,12-dodecanediol through Whole-Cell Biotransformation in <italic>Escherichia coli</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>84</volume> (<issue>4</issue>), <fpage>e01806</fpage>&#x2013;<lpage>e01817</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01806-17</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeon</surname>
<given-names>E.-Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.-W.</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>H.-J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.-M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.-B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Intracellular Transformation Rates of Fatty Acids Are Influenced by Expression of the Fatty Acid Transporter FadL in <italic>Escherichia coli</italic> Cell Membrane</article-title>. <source>J. Biotechnol.</source> <volume>281</volume>, <fpage>161</fpage>&#x2013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2018.07.019</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Julsing</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Cornelissen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Heme-iron Oxygenases: Powerful Industrial Biocatalysts?</article-title> <source>Curr. Opin. Chem. Biol.</source> <volume>12</volume> (<issue>2</issue>), <fpage>177</fpage>&#x2013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2008.01.029</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Julsing</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Schrewe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cornelissen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hermann</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Outer Membrane Protein AlkL Boosts Biocatalytic Oxyfunctionalization of Hydrophobic Substrates in <italic>Escherichia coli</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>78</volume> (<issue>16</issue>), <fpage>5724</fpage>&#x2013;<lpage>5733</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00949-12</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadisch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Julsing</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Schrewe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jehmlich</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Scheer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>von Bergen</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017a</year>). <article-title>Maximization of Cell Viability rather Than Biocatalyst Activity Improves Whole-Cell &#x3c9;-Oxyfunctionalization Performance</article-title>. <source>Biotechnol. Bioeng.</source> <volume>114</volume> (<issue>4</issue>), <fpage>874</fpage>&#x2013;<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1002/bit.26213</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadisch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Willrodt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hillen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017b</year>). <article-title>Maximizing the Stability of Metabolic Engineering-Derived Whole-Cell Biocatalysts</article-title>. <source>Biotechnol. J.</source> <volume>12</volume> (<issue>8</issue>), <fpage>1600170</fpage>. <pub-id pub-id-type="doi">10.1002/biot.201600170</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahng</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Byrne</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Kukor</surname>
<given-names>J. J.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Characterization and Role of <italic>tbuX</italic> in Utilization of Toluene by <italic>Ralstonia pickettii</italic> PKO1</article-title>. <source>J. Bacteriol.</source> <volume>182</volume> (<issue>5</issue>), <fpage>1232</fpage>&#x2013;<lpage>1242</lpage>. <pub-id pub-id-type="doi">10.1128/JB.182.5.1232-1242.2000</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Harayama</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>The TOL Plasmid pWW0 <italic>xylN</italic> Gene Product from <italic>Pseudomonas putida</italic> Is Involved in M-Xylene Uptake</article-title>. <source>J. Bacteriol.</source> <volume>183</volume> (<issue>22</issue>), <fpage>6662</fpage>&#x2013;<lpage>6666</lpage>. <pub-id pub-id-type="doi">10.1128/JB.183.22.6662-6666.2001</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kille</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zilly</surname>
<given-names>F. E.</given-names>
</name>
<name>
<surname>Acevedo</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Reetz</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Regio- and Stereoselectivity of P450-Catalysed Hydroxylation of Steroids Controlled by Laboratory Evolution</article-title>. <source>Nat. Chem.</source> <volume>3</volume> (<issue>9</issue>), <fpage>738</fpage>&#x2013;<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.1113</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xf6;nig</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brixius-Anderko</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Milhim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tavouli-Abbas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hutter</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Hannemann</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Identification and Circumvention of Bottlenecks in CYP21A2-Mediated Premedrol Production Using Recombinant <italic>Escherichia coli</italic>
</article-title>. <source>Biotechnol. Bioeng.</source> <volume>117</volume> (<issue>4</issue>), <fpage>901</fpage>&#x2013;<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1002/bit.27246</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kothari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Charrier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.-W.</given-names>
</name>
<name>
<surname>Malfatti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>S. W.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Transcriptomic Analysis of the Highly Efficient Oil-Degrading Bacterium <italic>Acinetobacter Venetianus</italic> RAG-1 Reveals Genes Important in Dodecane Uptake and Utilization</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>363</volume> (<issue>20</issue>), <fpage>fnw224</fpage>. <pub-id pub-id-type="doi">10.1093/femsle/fnw224</pub-id> </citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laemmli</surname>
<given-names>U. K.</given-names>
</name>
</person-group> (<year>1970</year>). <article-title>Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4</article-title>. <source>Nature</source> <volume>227</volume>, <fpage>680</fpage>&#x2013;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1038/227680a0</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ladkau</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Assmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schrewe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Julsing</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Efficient Production of the Nylon 12 Monomer &#x3c9;-aminododecanoic Acid Methyl Ester from Renewable Dodecanoic Acid Methyl Ester with Engineered <italic>Escherichia coli</italic>
</article-title>. <source>Metab. Eng.</source> <volume>36</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2016.02.011</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leive</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1974</year>). <article-title>The Barrier Function of the Gram-Negative Envelope</article-title>. <source>Ann. N. Y Acad. Sci.</source> <volume>235</volume> (<issue>1</issue>), <fpage>109</fpage>&#x2013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1974.tb43261.x</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lepore</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Indic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hearn</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Ligand-gated Diffusion across the Bacterial Outer Membrane</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>108</volume> (<issue>25</issue>), <fpage>10121</fpage>&#x2013;<lpage>10126</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1018532108</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leu</surname>
<given-names>Y.-L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P.-H.</given-names>
</name>
<name>
<surname>Shiao</surname>
<given-names>M.-S.</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>Y.-R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>A Novel Testosterone Catabolic Pathway in Bacteria</article-title>. <source>J. Bacteriol.</source> <volume>193</volume> (<issue>17</issue>), <fpage>4447</fpage>&#x2013;<lpage>4455</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00331-11</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Acevedo-Rocha</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>D&#x27;Amore</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Garcia-Borr&#xe1;s</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Regio- and Stereoselective Steroid Hydroxylation at C7 by Cytochrome P450 Monooxygenase Mutants</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source> <volume>59</volume> (<issue>30</issue>), <fpage>12499</fpage>&#x2013;<lpage>12505</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202003139</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Litzenburger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>CYP260B1 Acts as 9&#x3b1;-Hydroxylase for 11-deoxycorticosterone</article-title>. <source>Steroids</source> <volume>127</volume>, <fpage>40</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2017.08.006</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maloy</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Ginsburgh</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Simons</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Nunn</surname>
<given-names>W. D.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Transport of Long and Medium Chain Fatty Acids by <italic>Escherichia coli</italic> K12</article-title>. <source>J. Biol. Chem.</source> <volume>256</volume> (<issue>8</issue>), <fpage>3735</fpage>&#x2013;<lpage>3742</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9258(19)69516-5</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohn</surname>
<given-names>W. W.</given-names>
</name>
<name>
<surname>van der Geize</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dijkhuizen</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>The Actinobacterial <italic>Mce4</italic> Locus Encodes a Steroid Transporter</article-title>. <source>J. Biol. Chem.</source> <volume>283</volume> (<issue>51</issue>), <fpage>35368</fpage>&#x2013;<lpage>35374</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M805496200</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mounier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hakil</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Branchu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Na&#xef;tali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goulas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sivadon</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>AupA and AupB Are Outer and Inner Membrane Proteins Involved in Alkane Uptake in <italic>Marinobacter Hydrocarbonoclasticus</italic> SP17</article-title>. <source>mBio</source> <volume>9</volume> (<issue>3</issue>), <fpage>e00520</fpage>&#x2013;<lpage>00518</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.00520-18</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murdock</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ensley</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Serdar</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thalen</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Construction of Metabolic Operons Catalyzing the <italic>de novo</italic> Biosynthesis of Indigo in <italic>Escherichia coli</italic>
</article-title>. <source>Biotechnology (N Y)</source> <volume>11</volume> (<issue>3</issue>), <fpage>381</fpage>&#x2013;<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1038/nbt0393-381</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narhi</surname>
<given-names>L. O.</given-names>
</name>
<name>
<surname>Fulco</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Characterization of a Catalytically Self-Sufficient 119,000-dalton Cytochrome P-450 Monooxygenase Induced by Barbiturates in <italic>Bacillus megaterium</italic>
</article-title>. <source>J. Biol. Chem.</source> <volume>261</volume> (<issue>16</issue>), <fpage>7160</fpage>&#x2013;<lpage>7169</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9258(17)38369-2</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narhi</surname>
<given-names>L. O.</given-names>
</name>
<name>
<surname>Fulco</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Identification and Characterization of Two Functional Domains in Cytochrome P-450<sub>BM-3</sub>, a Catalytically Self-Sufficient Monooxygenase Induced by Barbiturates in <italic>Bacillus megaterium</italic>
</article-title>. <source>J. Biol. Chem.</source> <volume>262</volume> (<issue>14</issue>), <fpage>6683</fpage>&#x2013;<lpage>6690</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9258(18)48296-8</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikaido</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Molecular Basis of Bacterial Outer Membrane Permeability Revisited</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>67</volume> (<issue>4</issue>), <fpage>593</fpage>&#x2013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1128/mmbr.67.4.593-656.2003</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noble</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Miles</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Lysek</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>MacKay</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G. A.</given-names>
</name>
<etal/>
</person-group> (<year>1999</year>). <article-title>Roles of Key Active-Site Residues in Flavocytochrome P450 BM3</article-title>. <source>Biochem. J.</source> <volume>339</volume>, <fpage>371</fpage>&#x2013;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1042/bj3390371</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunn</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Simons</surname>
<given-names>R. W.</given-names>
</name>
</person-group> (<year>1978</year>). <article-title>Transport of Long-Chain Fatty Acids by <italic>Escherichia coli</italic>: Mapping and Characterization of Mutants in the <italic>fadL</italic> Gene</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>75</volume> (<issue>7</issue>), <fpage>3377</fpage>&#x2013;<lpage>3381</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.75.7.3377</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivera</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Luengo</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Steroids as Environmental Compounds Recalcitrant to Degradation: Genetic Mechanisms of Bacterial Biodegradation Pathways</article-title>. <source>Genes (Basel)</source> <volume>10</volume> (<issue>7</issue>), <fpage>512</fpage>. <pub-id pub-id-type="doi">10.3390/genes10070512</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Witholt</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wubbolts</surname>
<given-names>M. G.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>An Alkane-Responsive Expression System for the Production of fine Chemicals</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>65</volume> (<issue>6</issue>), <fpage>2324</fpage>&#x2013;<lpage>2332</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.65.6.2324-2332.1999</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A Chemoenzymatic Strategy for the Synthesis of Steroid Drugs Enabled by P450 Monooxygenase-Mediated Steroidal Core Modification</article-title>. <source>ACS Catal.</source> <volume>12</volume> (<issue>5</issue>), <fpage>2907</fpage>&#x2013;<lpage>2914</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.1c05776</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Putkaradze</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Litzenburger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hutter</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>CYP109E1 from <italic>Bacillus megaterium</italic> Acts as a 24- and 25-hydroxylase for Cholesterol</article-title>. <source>ChemBioChem</source> <volume>20</volume> (<issue>5</issue>), <fpage>655</fpage>&#x2013;<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201800595</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruff</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Arlt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>van Ohlen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kardashliev</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Konarzycka-Bessler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bocola</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>An Engineered Outer Membrane Pore Enables an Efficient Oxygenation of Aromatics and Terpenes</article-title>. <source>J. Mol. Catal. B Enzym</source> <volume>134</volume>, <fpage>285</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcatb.2016.11.007</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Sambrook</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>2001</year>). <source>Molecular Cloning: A Laboratory manual</source>. <publisher-loc>Cold Spring Harbor, NY</publisher-loc>: <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>. </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sch&#xe4;fer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Karande</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Maximizing Biocatalytic Cyclohexane Hydroxylation by Modulating Cytochrome P450 Monooxygenase Expression in <italic>P. Taiwanensis</italic> VLB120</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>8</volume>, <fpage>140</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2020.00140</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiffer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Anderko</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hobler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hannemann</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kagawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>A Recombinant CYP11B1 Dependent <italic>Escherichia coli</italic> Biocatalyst for Selective Cortisol Production and Optimization towards a Preparative Scale</article-title>. <source>Microb. Cel. Fact.</source> <volume>14</volume>, <fpage>25</fpage>. <pub-id pub-id-type="doi">10.1186/s12934-015-0209-5</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kochanowski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vedelaar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ahrn&#xe9;</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Volkmer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Callipo</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The Quantitative and Condition-dependent <italic>Escherichia coli</italic> Proteome</article-title>. <source>Nat. Biotechnol.</source> <volume>34</volume> (<issue>1</issue>), <fpage>104</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3418</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmitz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zapp</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Steroid Conversion with CYP106A2 - Production of Pharmaceutically Interesting DHEA Metabolites</article-title>. <source>Microb. Cel. Fact.</source> <volume>13</volume>, <fpage>81</fpage>. <pub-id pub-id-type="doi">10.1186/1475-2859-13-81</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wubbolts</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Sanglard</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Witholt</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Biocatalyst Engineering by Assembly of Fatty Acid Transport and Oxidation Activities for <italic>In Vivo</italic> Application of Cytochrome P-450<sub>BM-3</sub> Monooxygenase</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>64</volume> (<issue>10</issue>), <fpage>3784</fpage>&#x2013;<lpage>3790</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.64.10.3784-3790.1998</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schrewe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Magnusson</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Willrodt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Kinetic Analysis of Terminal and Unactivated C-H Bond Oxyfunctionalization in Fatty Acid Methyl Esters by Monooxygenase-Based Whole-Cell Biocatalysis</article-title>. <source>Adv. Synth. Catal.</source> <volume>353</volume> (<issue>18</issue>), <fpage>3485</fpage>&#x2013;<lpage>3495</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201100440</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schrewe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Julsing</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Whole-cell Biocatalysis for Selective and Productive C-O Functional Group Introduction and Modification</article-title>. <source>Chem. Soc. Rev.</source> <volume>42</volume> (<issue>15</issue>), <fpage>6346</fpage>&#x2013;<lpage>6377</lpage>. <pub-id pub-id-type="doi">10.1039/c3cs60011d</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schrewe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Julsing</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Czarnotta</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>B&#xfc;hler</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Reaction and Catalyst Engineering to Exploit Kinetically Controlled Whole-Cell Multistep Biocatalysis for Terminal FAME Oxyfunctionalization</article-title>. <source>Biotechnol. Bioeng.</source> <volume>111</volume> (<issue>9</issue>), <fpage>1820</fpage>&#x2013;<lpage>1830</lpage>. <pub-id pub-id-type="doi">10.1002/bit.25248</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schubeis</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Le Marchand</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Daday</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kopec</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tekwani Movellan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stanek</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>A &#x3b2;-barrel for Oil Transport through Lipid Membranes: Dynamic NMR Structures of AlkL</article-title>. <source>Proc. Natl. Acad. Sci. U S A.</source> <volume>117</volume> (<issue>35</issue>), <fpage>21014</fpage>&#x2013;<lpage>21021</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2002598117</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staijen</surname>
<given-names>I. E.</given-names>
</name>
<name>
<surname>van Beilen</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Witholt</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Expression, Stability and Performance of the Three-Component Alkane Mono-Oxygenase of <italic>Pseudomonas oleovorans</italic> in <italic>Escherichia coli</italic>
</article-title>. <source>Eur. J. Biochem.</source> <volume>267</volume> (<issue>7</issue>), <fpage>1957</fpage>&#x2013;<lpage>1965</lpage>. <pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01196.x</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Straathof</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Panke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The Production of fine Chemicals by Biotransformations</article-title>. <source>Curr. Opin. Biotechnol.</source> <volume>13</volume> (<issue>6</issue>), <fpage>548</fpage>&#x2013;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1016/s0958-1669(02)00360-9</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szaleniec</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wojtkiewicz</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Borowski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Donova</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Bacterial Steroid Hydroxylases: Enzyme Classes, Their Functions and Comparison of Their Catalytic Mechanisms</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>102</volume> (<issue>19</issue>), <fpage>8153</fpage>&#x2013;<lpage>8171</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-018-9239-3</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>W.-Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Microbial Biotransformation: Recent Developments on Steroid Drugs</article-title>. <source>Recent Pat Biotechnol.</source> <volume>3</volume> (<issue>2</issue>), <fpage>141</fpage>&#x2013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.2174/187220809788700157</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urlacher</surname>
<given-names>V. B.</given-names>
</name>
<name>
<surname>Eiben</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Cytochrome P450 Monooxygenases: Perspectives for Synthetic Application</article-title>. <source>Trends Biotechnol.</source> <volume>24</volume> (<issue>7</issue>), <fpage>324</fpage>&#x2013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2006.05.002</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urlacher</surname>
<given-names>V. B.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>R. D.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Recent Advances in Oxygenase-Catalyzed Biotransformations</article-title>. <source>Curr. Opin. Chem. Biol.</source> <volume>10</volume> (<issue>2</issue>), <fpage>156</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2006.02.001</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Beilen</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Eggink</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Enequist</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bos</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Witholt</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>DNA Sequence Determination and Functional Characterization of the OCT-Plasmid-Encoded <italic>alkJKL</italic> Genes of <italic>Pseudomonas oleovorans</italic>
</article-title>. <source>Mol. Microbiol.</source> <volume>6</volume> (<issue>21</issue>), <fpage>3121</fpage>&#x2013;<lpage>3136</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.1992.tb01769.x</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Beilen</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Duetz</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Witholt</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Practical Issues in the Application of Oxygenases</article-title>. <source>Trends Biotechnol.</source> <volume>21</volume> (<issue>4</issue>), <fpage>170</fpage>&#x2013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/S0167-7799(03)00032-5</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Berg</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>P. N.</given-names>
</name>
<name>
<surname>Clemons</surname>
<given-names>W. M. J.</given-names>
</name>
<name>
<surname>Rapoport</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Crystal Structure of the Long-Chain Fatty Acid Transporter FadL</article-title>. <source>Science</source> <volume>304</volume> (<issue>5676</issue>), <fpage>1506</fpage>&#x2013;<lpage>1509</lpage>. <pub-id pub-id-type="doi">10.1126/science.1097524</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Berg</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>The FadL Family: Unusual Transporters for Unusual Substrates</article-title>. <source>Curr. Opin. Struct. Biol.</source> <volume>15</volume> (<issue>4</issue>), <fpage>401</fpage>&#x2013;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2005.06.003</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Berg</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Going Forward Laterally: Transmembrane Passage of Hydrophobic Molecules through Protein Channel walls</article-title>. <source>ChemBioChem</source> <volume>11</volume> (<issue>10</issue>), <fpage>1339</fpage>&#x2013;<lpage>1343</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201000105</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Nuland</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Eggink</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Weusthuis</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Application of AlkBGT and AlkL from <italic>Pseudomonas putida</italic> GPo1 for Selective Alkyl Ester &#x3c9;-oxyfunctionalization in <italic>Escherichia coli</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>82</volume> (<issue>13</issue>), <fpage>3801</fpage>&#x2013;<lpage>3807</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00822-16</pub-id> </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Vugt-Lussenburg</surname>
<given-names>B. M. A.</given-names>
</name>
<name>
<surname>Damsten</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Maasdijk</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Vermeulen</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Commandeur</surname>
<given-names>J. N. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Heterotropic and Homotropic Cooperativity by a Drug-Metabolising Mutant of Cytochrome P450 BM3</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>346</volume> (<issue>3</issue>), <fpage>810</fpage>&#x2013;<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.05.179</pub-id> </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venkataraman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>te Poele</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Ros&#x142;oniec</surname>
<given-names>K. Z.</given-names>
</name>
<name>
<surname>Vermeulen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Commandeur</surname>
<given-names>J. N. M.</given-names>
</name>
<name>
<surname>van der Geize</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Biosynthesis of a Steroid Metabolite by an Engineered <italic>Rhodococcus erythropolis</italic> Strain Expressing a Mutant Cytochrome P450 BM3 Enzyme</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>99</volume> (<issue>11</issue>), <fpage>4713</fpage>&#x2013;<lpage>4721</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-014-6281-7</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rawlings</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>D. T.</given-names>
</name>
<name>
<surname>Labb&#xe9;</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bergeron</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Brousseau</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>1995</year>). <article-title>Identification of a Membrane Protein and a Truncated LysR-type Regulator Associated with the Toluene Degradation Pathway in <italic>Pseudomonas putida</italic> F1</article-title>. <source>Mol. Gen. Genet.</source> <volume>246</volume> (<issue>5</issue>), <fpage>570</fpage>&#x2013;<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1007/BF00298963</pub-id> </citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitehouse</surname>
<given-names>C. J. C.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>L.-L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>P450<sub>BM3</sub> (CYP102A1): Connecting the Dots</article-title>. <source>Chem. Soc. Rev.</source> <volume>41</volume> (<issue>3</issue>), <fpage>1218</fpage>&#x2013;<lpage>1260</lpage>. <pub-id pub-id-type="doi">10.1039/c1cs15192d</pub-id> </citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woodley</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Microbial Biocatalytic Processes and Their Development</article-title>. <source>Adv. Appl. Microbiol.</source> <volume>60</volume>, <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-2164(06)60001-4</pub-id> </citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zehentgruber</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dr&#x1ce;gan</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Bureik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>L&#xfc;tz</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2010a</year>). <article-title>Challenges of Steroid Biotransformation with Human Cytochrome P450 Monooxygenase CYP21 Using Resting Cells of Recombinant <italic>Schizosaccharomyces pombe</italic>
</article-title>. <source>J. Biotechnol.</source> <volume>146</volume> (<issue>4</issue>), <fpage>179</fpage>&#x2013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2010.01.019</pub-id> </citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zehentgruber</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hannemann</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bleif</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>L&#xfc;tz</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2010b</year>). <article-title>Towards Preparative Scale Steroid Hydroxylation with Cytochrome P450 Monooxygenase CYP106A2</article-title>. <source>ChemBioChem</source> <volume>11</volume> (<issue>5</issue>), <fpage>713</fpage>&#x2013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.200900706</pub-id> </citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Acevedo-Rocha</surname>
<given-names>C. G.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Bacterial Cytochrome P450-Catalyzed Regio- and Stereoselective Steroid Hydroxylation Enabled by Directed Evolution and Rational Design</article-title>. <source>Bioresour. Bioproc.</source> <volume>7</volume>, <fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/s40643-019-0290-4</pub-id> </citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Exploring the Potential of Cytochrome P450 CYP109B1 Catalyzed Regio-And Stereoselective Steroid Hydroxylation</article-title>. <source>Front. Chem.</source> <volume>9</volume>, <fpage>649000</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2021.649000</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>